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Candida albicans is a fungal pathogen of humans, which may cause fatal 
disease. Unfortunately, current treatment against Candida infection is hampered by 
different factors, for example, the emergence of fungal species with drug resistance. 
Photodynamic therapy (PDT) can offer an alternative treatment for this disease. 
Hence in the present study, the antifungal effect of a photosensitizer, an 
unsymmetrical bisamino substituted silicon(IV) phthalocyanine BAM-SiPc, against 
C. albicans was investigated. This photosensitizer has been shown to act against 
different cancer cells in previous studies. Its antifungal activity was determined 
here for the first time using the planktonic and biofilm models of C. albicans. 
BAM-SiPc was effective in killing planktonic C. albicans. The I C 5 0 value 
was 0.011 |iM. The photo-inactivation was drug-dose-dependent and 
light-dose-dependent. In the absence of light, no toxicity was detected. A higher 
density of cells showed a greater resistance towards the photodynamic treatment. A 
pre-incubation period of 5 to 15 minutes with BAM-SiPc was sufficient to exert its 
optimal antifungal effect. Further incubation did not show any increase in its 
efficacy. Confocal microscopic analyses confirmed that BAM-SiPc was 
internalized and located inside the yeast cells. Further studies showed that there 
was a drug-dose-dependent increase in the generation of intracellular reactive oxygen 
iii 
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species (ROS) after the PDT treatment. The results of propidium iodide staining 
suggested that the cell membrane might be one of the critical oxidative damage sites 
responsible for the noted cytotoxicity. 
On the other hand, BAM-SiPc did not show any antifungal effect in the C. 
albicans biofilm model under the experimental conditions employed, the reason 
remains unknown. Nevertheless, preliminary results showed that the 
photosensitizer could still be uptaken into the cell. However, compared with the 
planktonic situation, there was a reduced ROS production. This, together with the 
complexity and integrity of the biofilm structure, might be responsible for the 
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Chapter 1 Introduction 
Chapter 1 
Introduction 
1.1 Candida albicans and candidiasis 
1.1.1 Historical background 
“Thrush,’ is a kind of candidiasis. Although it has been described for 
hundreds of year, confusion on the organism causing the disease still existed until 
1954 when the Eighth Botanical Congress officially adopted the binomial “Candida 
albicans “ as the nomen conservandum (Calderone 2002). 
Fungi are eukaryotes which are distinct from plants and animals. More than 
100,000 species of fungi have been identified. However, not all of them cause 
infections in human or animals. Only about 100 fungal species are known to be 
regularly causing mycoses, among them is Candida albicans (Muller and Polak, 
2003). C. albicans is an unicellular fungal pathogen. Its natural habitats include the 
oral cavity, gastrointestinal tract and vulvovaginal regions of warm-blooded animals. 
Usually, it exists as part of the normal flora without causing any disease or clinical 
symptoms. However, alteration of host immunity, bacterial flora or other 
environmental factors may cause its overgrowth and result in infections (Pappas et 
al., 2004, Samaranayake and MacFarlane, 1990). 
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1.1.2 C. albicans infections 
Over the last few decades, infections of Candida spp. are becoming more and 
more prevalent among the microbial infections. Different sentinel systems have been 
established for the surveillance of fungal infections. For example, the National 
Nosocomial Infections Surveillance (NNIS) system was established by the Centers 
for Disease Control and Prevention in 1970 (Banerjee et al., 1991). Several 
population-based surveillance studies have indicated that Candida infection ranked 
as the fourth most common cause (9%) of hospital-acquired bloodstream infection in 
the United States, after the three bacterial infections of coagulase-negative 
staphylococci (31%), Staphylococcus aureus (20%) and enterococci (9%) (Edmond 
et al” 1999; Wisplinghoff et al., 2004). Such a high ranking exists not only in a 
Western country; for example, it has also been reported that Candida infection is 
very common in patients at the National Taiwan University Hospital in Taiwan 
(Chen et al., 1997). The attributable mortality rate due to bloodstream infections by 
Candida spp. is even higher, approaching 35% (Pittet and Wenzel, 1995). Although 
there is a gradual increase in the proportion of infections caused by non-albicans 
species, e.g. C. glabrata, C. parapsilosis and C. tropicalis, C. albicans remains the 
most predominant one and accounts for 〜45o/o of the clinical isolates (Hajjeh et al., 
2004). 
2 
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1.1.3 Current challenges in the treatment of C. albicans 
The reasons behind the outbreak of candidiasis in recent era are mainly the 
increasing size of population at risk and the development of antimicrobial drug 
resistance. 
Patients at risk with candidiasis 
Candida spp. causes infections of skin and mucous membrane in both 
immunocompromised and non-immunocompromised patients. On the other hand, 
systemic candidiasis mainly occurs in severely immunocompromised patients. 
While modern, advanced medical technologies cure more and more diseases, they 
generate, in turn, more immunocompromised patients who are at risk of infections. 
For examples, patients with solid-organ transplantation coupled with prolonged 
immunosuppressive therapy (Patterson, 1999; Pugliese et al., 2007) and also patients 
in the intensive care unit using intravascular catheters, broad-spectrum antibiotic are 
more prone to infection (Kullberg and Filler, 2002). Besides, the rapid increase in 
the number of HIV-infected, diabetes mellitus and cancer patients causes a further 
increase in the high-risk population towards candidiasis (Kao et al., 1999). 
Antifungal drugs and resistance 
3 
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Intensive use of antimicrobial drug and antibiotics not only induces drug 
resistance in bacteria, it also kills the flora which suppress the growth of C. albicans 
and results in its overgrowth. 
Four major groups of antifungal drugs targeting C. albicans are present 
nowadays, namely pyrimidine, polyenes, azole and echinocandins. 5-Fluorocytosine 
(5-FC) is a kind of fluorinated pyrimidine which can cause aberrant R N A synthesis 
and interfere with D N A replication. Amphotericin B and nystatin are polyenes with 
heterocyclic amphipathic characteristics. They can insert into the lipid bilayer of 
yeasts, bind to the sterols and aggregate in annuli to form poles. This eventually will 
disrupt the integrity of the plasma membrane and cause the efflux of cations, for 
example K+. The azole drugs, for example triazole fluconazole, interrupt the 
ergosterol biosynthetic pathway by inhibiting cytochrome P450 14a-lanosterol 
demethylase. This leads to an accumulation of toxic intermediates in the sterol 
pathway and thus inhibits the growth of cells. The cyclic lipopeptides, 
echinocandins, are the most recently developed class of antifungal agents. They 
exert the fungicidal effect by inhibiting (l,2)-D-(3-glucan synthase, an enzyme 
involved in cell wall biosynthesis (Cannon et al., 2007). 
The intensive use of antifungal drugs, unfortunately, causes selection for the 
resistance strains of Candida spp. A number of resistance mechanisms have been 
identified; for examples, mutation in enzymes which reduce the affinity towards the 
4 
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antifungal drugs, overepression of enzymes inhibited by the drug, overexpression of 
multidrug transporters or pumps which cause efflux of the drugs. An overview of the 
drug resistance mechanisms is shown in Table 1 (Sanglard and Bille, 2002). 
5 
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Table 1.1. An overview of the action mode and resistance mechanisms of 
different antifungal agents against Candida species (adopted from Sanglard and 
Bille, 2002). 
A _ , , � � I , / � r Mechanism(s) of resistance in 
Antifungal agent(s) Mode(s) of action laboratory isolates 
Amphotericin B Binding to ergosterol � Absence of ergosterol or 
decrease of ergosterol 
content in cells 
� Increased catalase activity 
5-Fluorocytosine Inhibition of DNA synthesis 今 Defect in cytosine permease 
� Deficiency or lack of 
enzymes implicated in the 
metabolism of 5-FC 
� Deregulation of the 
pyrimidine biosynthetic 
pathway 
Azoles (ketoconazole, Inhibition of 14a-lanosterol � Enhanced efflux mediated by 
itraconazole, fluconazole, demethylase {ERG 11) multidrug transporters 
voriconazole, 令 Decrease of affinity in 14a-
posaconazole, lanosterol demethylase by 
rauconazole) mutations 
� Upregulation of ERG 11 
今 Alterations in the ergosterol 
biosynthetic pathway 
Allylamines (terbinafine) Inhibition of squalene *N.R. 
epoxidase 
Morpholines (amorolfine) Inhibition of sterol A" *N.R. 
reductase {ERG24) and the 
八7-8 isomerase {ERG2) 
Griseofulvin Binding to tubulin *N.R. 
Cyclic lipopeptides Inhibition of P-1,3 glucan � Loss of (3-1,3 glucan synthase 
(caspofungin, synthase (CaFKSI) function 
micafungin, V-
echinocandin) 
Nikkomycin Z Inhibition of chitin *N.R. 
synthase 
Pradimicins Calcium-dependent binding *N.R. 
to mannan 
Sordarins Inhibition of elongation *N.R. 
factor 2 {EFT2) 
Cationic antimicrobial Formation of pores at the � Loss of mitochondrial 
peptides site of cellular membranes function 
*N.R.: Not reported 
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Polymorphism and biofilm of C. albicans 
Development of drug resistance is just one of the current challenges. Further 
barriers include the polymorphic feature of Candida spp. and the biofilm formation. 
Many pathogenic fungi, including C. albicans, exhibit different morphologies under 
different environmental conditions. Most C. albicans could grow in three forms, viz. 
budding yeast or blastoconidia (Figure 1.1a), pseudohyphae (Figure 1.1b) and true 
hyphae (Figure 1.1c) with septa (Mitchell, 1998). The polymorphism or the 
transition of blastospore formation to hyphal formation contributes to C. albicans' 
virulence and its ability to cause diseases. Molecular genetic analyses have shown 
that genes controlling filamentous morphology are co-regulated with the genes 
encoding conventional virulence factors, such as proteases and adhesins. Also, 
hyphae possess functions like exerting mechanical force which aids (i) penetration of 
epithelial surfaces, and (ii) escape from the bloodstream into deeper tissues 
(Kumamoto and Vinces, 2005). 
The majority of microorganisms would prefer to attach onto surfaces to form 
a structured biofilm ecosystem rather than exist in the planktonic form. Biofilms are 
universal, complex, interdependent communities of surface associated 
microorganisms, which may be homogeneous or heterogeneous. The microbial 
community is usually enclosed within a protective exopolysaccharide matrix. It has 
7 
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Figure 1.1 Polymorphism of C. albicans. The morphologies of three different 
forms of C. albicans: (a) Yeast cell (b) pseudohyphae (c) hyphae. (adopted from 
Herman, 2006) 
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been estimated that about 65% of all human microbial infections involve biofilms 
(Jabra-Rizk et al., 2004; Ramage et al., 2006). With the developments of advanced 
light microscopes and microelectrode technology, scientists are beginning to get 
some cues on the infrastructure and functional heterogeneity of the microcolonies in 
the biofilms (Costerton et al., 1999). 
C. albicans is one of the microorganisms capable of forming a biofilm. Its 
developmental and structural characteristics are unique and different from bacteria as 
it is capable of dimorphic switching. The widespread use of different medical 
implant devices, for example central venous catheters, implantable venous access 
ports, prosthetic joints voice prostheses and dentures, which provide surfaces for 
biofilm formation, is one of the factors for the increase of Candida infections. The 
increased resistance of the cells in biofilm leads to the frequent removal of the 
devices (Chandra et al., 2001; Nobile and Mitchell, 2006; Ramage et al., 2006). 
The C. albicans biofilms are a nuisance for physicians as the sessile cells in 
biofilms show a dramatically different phenotype from the planktonic ones with a 
strong resistance towards antifungal drugs. The mature C. albicans biofilm has a 
complex, three dimensional structure with extensive spatial heterogeneity. The 
dense network of the yeast, hyphae and pseudohyphae is encased within the 
exopolymeric material. Such spatial arrangement facilitates the intake of nutrients 
and the removal of wastes. On disease pathogenesis, the most concerning feature is 
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the high resistance of the cells to antifungal agents. When compared with the 
planktonic cells of C. albicans, the cells growing in biofilm were 100-fold more 
resistant to fluconazole and 20-30 fold more resistant to amphotericin B, both are 
typical antifungal drugs clinically in use. Unfortunately, the underlying reason is 
still not fully understood (Kumamoto, 2002; Lopez-Ribot, 2005). 
Need for alternative treatments 
To cope with the challenges, such as the increasing incidence of Candida 
infections and drug resistance, many investigators are searching for new antifungal 
drugs. Although the recently developed antifungal drugs, including the 
echincocandins (the first member of the lipopeptide group) and secondary triazoles, 
show high potency in treating fungal infections (Shao et al., 2007), alternative 
treatment modalities with different mechanisms to those of the conventional 
antibiotics may also help. 
10 
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1.2 Photodynamic therapy 
Phototherapy is the use of light (ultraviolet, visible or near infrared) in the 
treatment of diseases. Photodynamic therapy (PDT) is a subset of phototherapy that 
requires the administration of a photosensitizer in the presence of molecular oxygen 
at the ambient level, together with the illumination of the corresponding visible or 
near infrared light to have the therapeutic effect (Bonnett, 2000a). 
1.2.1 Historical aspects and development 
PDT had been used for a long time, even before its principle was recognized. 
Back to ancient Egypt, India and China, phototherapy and photochemotherapy have 
already been used for the treatments of rickets, psychosis and skin diseases, such as 
psoriasis, vitiligo and cancer (Epstein, 1990). Better understanding began from the 
twentieth century through the investigations of Niels Finsen, Oscar Raab and 
Herman von Tappeiner. 
Finsen is the person who first used phototherapy in a scientific way. He is 
generally regarded as the father of this subject. He used red light to prevent 
suppuration and scarring in patients with smallpox, and also ultraviolet light to treat 
cutaneous tuberculosis (Bonnett, 2000b; Ackroyd et al., 2001). Finsen was awarded 
the Nobel Prize for Physiology-Medicine in 1903, after that people started to pay 
more attention to PDT. 
11 
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The discovery of PDT occurred in 1897 when Raab, a medical student under 
the supervision of von Tappeiner, studied the effect of acridine red on Paramecia. 
He found that, after the application of acridine red as the photosensitizer, the 
Paramecia were killed in the daylight but survived in darkness. Since then, von 
Tappeiner proposed different dermatological applications for PDT, such as using 
eosin and white light to treat skin cancer in 1903, and further demonstrated the need 
of oxygen in photodynamic action (Bonnett, 2000b; Ackroyd et al., 2001). 
Hematoporphyrin (Hp), another photosensitizer, was first produced by 
Scherer in 1841 during his investigation on blood. Schwartz et al. (1955) produced a 
hematoporphyrin derivative (HpD) by modifying Hp, which shows greater 
phototoxicity than the crude Hp. In the early stage, studies on Hp, porphyrin and 
HpD were mainly focused on their use for tumor detection. A major breakthrough of 
PDT for clinical use occurred in 1970s when Kelly and Snell reported the use of PDT 
with HpD in five patients with bladder cancer. Meanwhile, Dougherty also reported 
the successful treatments of skin tumors in human with HpD. Later in 1993, a drug 
grade HpD, Photofrin®, was approved by the health agency in Canada for use in the 
treatment of bladder cancer. It is now approved also by the F D A in US and licensed 
in many countries for the treatment of different cancers, such as those in the lung, 
cervix and esophagus (Ackroyd et al., 2001). Though there is a rapid development 
of new photosensitizers, only a few have received official approval at present. The 
12 
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list includes Photofrin® (porfimer sodium), Foscan® (temoporfrin), Visudyne⑧ 
(verteporfm), Levulan® (5-aminolevulinic acid, ALA) and Metvix® (methyl 
aminolevulinate, M L A or M-ALA) (Figure 1.2) (Huang, 2005). 
1.2.2 Basic principle of photodynamic therapy 
Photodynamic therapy requires three important components, the 
photosensitizer, oxygen and light. The three components are nontoxic individually, 
but generate a therapeutic effect when combined. The mechanism of the 
photodynamic action can be divided into two categories, referred to as Type I and 
Type II processes. The first step of the two processes is basically the same, which 
involves the absorption of a light photon by the photosensitizer in the ground state 
(with no unpaired electron spin) and activating it to the short-lived excited singlet 
state. The singlet state may decay back to the ground state directly through the 
emission of fluorescence, which enables the use of photosensitizers for 
photodetection as fluorescence dyes, such as acridine for the staining of nucleic acids. 
In order to have the therapeutic photodynamic effect, the singlet state photosensitizer 
must undergo electron spin conversion to the more stable and long lived triplet state, 
which can then go through either Type I or Type II process (Bonnett, 2000b; 
Dolmans et al., 2003; Calzavara-Pinton et al” 2007). 
13 
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Figure 1.2 Structures of several clinically approved photosensitizers. (a) 
Photofrin®, (b) Foscan®, (c) Visudyne®, (d) Levulan®, (e) Metvix®. 
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Type I process- Electron transfer / Hydrogen abstraction 
In this mechanism, the triplet state photosensitizer generates radical species 
by electron transfer from (or to) a substrate, or by hydrogen abstraction from a 
substrate, such as cell membrane or any molecule. After the transfer, the 
photosensitizer usually returns to the ground state. The reactive intermediates 
formed, such as superoxide, hydroperoxyl radical, hydroxyl radical, and hydrogen 
peroxide, may cause damage to cells (Bonnett, 2000b; Calzavara-Pinton et al., 2007). 
Type II process- Energy transfer 
In Type II photoprocess, there is a direct transfer of electronic excitation 
energy from the triplet state photosensitizer to the ground state triplet dioxygen (^ 62), 
which results in the production of cytotoxic excited singlet state oxygen ('O2). The 
photosensitizer returns to its original ground state afterwards (Bonnett, 2000b; 
Calzavara-Pinton et al., 2007). 
Type I and Type II reactions occur simultaneously when the photosensitizer 
is illuminated. The ratio of the two reactions varies with the types of photosensitizer, 
the concentrations of substrate and oxygen and the binding affinity of the 
photosensitizer for the substrate (Dolmans et al., 2003). 
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Singlet oxygen - the major mediator of phototoxicity 
Although both Type I and Type II reactions can generate reactive oxygen 
species (ROS) and cause oxidation of biomolecules, the singlet oxygen formed in the 
Type II mechanism is usually regarded as the most damaging species. It is highly 
reactive because it only requires very low excitation energy (0.98 eV) for activation 
which can then cause various oxidative processes (Cumpston et al” 1997). The half-
life of singlet oxygen is very short, less than 0.04 [is in biological system. This makes 
the radius of action shorter than 0.02 |im (Moan and Berg, 1991). 
1.2.3 Light applicator 
Various kinds of light source have been used in PDT, including sunlight, 
incandescent lamps, arc lamps, light emitting diodes (LED) and lasers. The first 
light source described in PDT was conventional lamp which provides non-coherent 
light (with spectra of light). Conventional lamps are inexpensive and can activate 
various photosensitizers. However, the drawbacks, such as significant thermal effect 
and difficulty in calculating the light dose, made people look for other sources such 
as lasers. Lasers can produce high-energy monochromatic light (with a specific 
narrow bandwidth wavelength) corresponding to the absorption peak of the 
photosensitizer, so that the calculation of light dose is more accurate. It also has 
reduced thermal effect. The laser light can pass through an optical fiber and be 
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delivered directly onto the target site (Bonnett, 2000c; Ackroyd et al., 2001; Pervaiz 
and Olivo, 2006). 
1.2.4 Generations of photosensitizer 
The photosensitizer is the most important component of PDT. Most of the 
photosensitizers have a heterocyclic ring structure, similar to that in chlorophyll or 
hemoglobin. They can be classified into three major broad families according to 
their chemical structures and origins, viz. porphyrin-based photosensitizer (such as 
HpD, ALA, texaphyrins), chlorophyll-based photosensitizer (such as chlorines, 
purpurins) and dye (such as phthalocyanine and napthalocyanine) (Huang, 2005; 
Pervaiz and Olivo, 2006). The development and improvement of photosensitizers is 
still a hot topic, and there are three generations of photosensitizers up to the present 
moment. 
First generation photosensitizers 
The first generation of photosensitizers includes the porphyrins, HpD and 
those developed in the 1970s and early 1980s (Huang, 2005). These photosensitizers 
have the advantage that they are easily prepared by a simple procedure from readily 
available raw materials. Also, there are extensive clinical experiences established. 
However, they are complex mixtures with different isomerisms, steroisomerisms, 
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oligomeric compositions and natures of the inter-porphyrin linkages. The 
complexity makes it difficult to reproduce and there may be variations of 
phototoxicity in different mixtures. Besides, HpD has a long retention period, which 
may be up to ten weeks, after the injection. This will cause a long post-treatment 
photosensitivity to the patient who needs to avoid sunlight. There are a number of 
absorption peaks between 400 and 650 nm in Photofrin. The weakest one at 630 nm 
is generally used for excitation because the longer the wavelength, the greater is the 
penetrating power. As a result, it requires a higher photosensitizer dose or higher 
light dose to compensate for the weak absorption for effective treatment (Sharman et 
al., 1999; Bonnett, 2000d). 
Second generation photosensitizers 
The several significant drawbacks of the first generation photosensitizers call 
for the need of the second generation photosensitizers. The second generation 
photosensitizers include the porphyrin derivatives and synthetics made from the late 
1980s, such as ALA. Bonnett (2000d) and Sharman et al. (1999) have summarized 
the criteria for an ideal photosensitizer as follows: 
(i) Composition: It should be chemically pure and of known and constant 
composition; 
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(ii) Dark toxicity: The photosensitizer should have minimal dark toxicity and 
only be cytotoxic upon illumination; 
(iii) Synthesis: The synthesis procedures should be straightforward with high-
yield; 
(iv) Solution behavior: It is better to be preferentially retained by the target 
tissue, but with a rapid clearance from the body after treatment to minimize 
the systemic toxicity; 
(v) Delivery system: Different delivery systems, like the use of detergent-like 
molecules, inclusion complexes and lipoprotein carriers, could be used to 
solubilise or increase the selectivity or targeting of the photosensitizer; 
(vi) Photophysical properties: It should have a high photochemical reactivity, ie. 
with a high triplet state yield with long life-time, and produce singlet oxygen 
and other ROS effectively; 
(vii) Red absorption: It should have a strong absorbance with a high extinction 
coefficient at a longer wavelength (e.g. 600—800 nm), as the penetration of 
light into tissues is at a maximum while the light is still energetic enough to 
produce singlet oxygen. 
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Third generation photosensitizers 
In view of the importance of improving the properties of photosensitizers 
such as the selectivity, investigations of the third generation photosensitizers are now 
in progress. The third generation photosensitizers are generally regarded as the 
photosensitizers with modifications such as biologic conjugates (with antibodies and 
liposome) and the built-in photo quenching or bleaching capability (Huang, 2005). 
1.2.5 Characteristics of phthalocyanines 
Phthalocyanines (Pc) belong to the major class of dye among the 
photosensitizers. They have been used as dyes and colouring agents for a long time, 
and were later discovered to be effective photosensitizers. The basic structure of Pc 
is formed by joining four benzenes to the (3-pyrrolic positions of porphyrins and 
substituting the methine-bridge carbons with nitrogen (Figure 1.3) (Calzavara-Pinton 
2007). 
N N 
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Figure 1.3 Basic structure of phthalocyanine. 
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The extension of the benzene groups increases the aromatic character and 
strengthens the absorption of light at a longer wavelength when compared with the 
original porphyrin (Sharman et al., 1999). Besides possessing the high singlet 
oxygen quantum yield and high extinction coefficient in the far red region (670-700 
nm), Pc also has the unique feature of the modifiable central metal ligand and side 
chains. The central metal ligand is critical for the photobiological property as it 
influences the triplet yield and the triplet lifetime of the PS, while the side chains 
influence the polarity. As the macrocyclic nucleus is strongly hydrophobic, polar or 
hydrophilic substituents such as hydroxyl, sulphonic acid and quarternary 
ammonium groups are usually linked to avoid solubility problem (Wainwright, 1998; 
Bonnett, 2000e; Calzavara-Pinton et al., 2005). 
Common examples of phthalocyanines include aluminium(III) 
phthalocyanine (AlPc), zinc(II) phthalocyanine (ZnPc) and silicon(IV) 
phthalocyanine (SiPc or Pc 4). Many studies have indicated that phthalocyanines 
are effective photosensitizers for treating various diseases. For example, Pc 4 was 
selected for intensive studies at the Case Western Reserve University in Cleveland, 
and some Phase I clinical trials were performed in the University Hospital. The 
results showed that it is useful in treating cutaneous T-cell lymphoma and Pc 4 is a 
possible inducer of apoptosis (Miller et al., 2007). Not only for cancer, Pc is also 
useful in treating protozoans (e.g. Plasmodium falciparum) (Lustigman and Ben-Hur, 
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1996), bacteria (e.g. methicillin-resistant Staphylococcus aureus) (Wilson and 
Pratten, 1995), fungi (e.g. C. albicans) (Bertoloni et al., 1992) and viruses (e.g. HIV, 
V S V and HSV) (Rywkin et al., 1994; Semtana et al., 1994; Ben-Hur et al., 1995). 
1.2.6 Photodynamic antimicrobial chemotherapy (PACT) 
Investigations of the applications of PDT were mainly focused in the field of 
oncology in the past century. Intensive studies on PDT have been performed on 
various types of cancer, such as skin caner, head and neck cancer, brain tumor, 
pulmonary and pleural mesothelial cancer, gastroenterological cancer and prostate 
cancer, etc (Huang, 2005; Qiang et al., 2006). In fact, the applications of PDT are 
multiple, which also include non-malignant diseases, like those in the fields of 
ophthalmology (e.g. subfoveal choroidal neovascularisation), cardiology (e.g. 
atherosclerosis), dermatology (e.g. microbial infection, acne, vulgaris, psoriasis), 
rheumatology (e.g. arthritis) and microbiology (viral, bacterial and fungal infection) 
(Moan and Berg, 1991; Huang, 2005; Qiang et al., 2006). 
Advantages of PACT 
Despite the first record of PDT by Raab over 100 years ago on the 
inactivation of Paramecium caudatum (Ackroyd et al., 2001), the use of PDT in the 
treatment of microbial infection is regarded as a new emerging field. The potential 
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of P A C T has not been fully exploited in the early twentieth century. It is because of 
the discovery of the powerful antibiotics which are supposed to be effective for 
curing most microbial infections. The poor responses of traditional photosensitizers 
in the early investigation also hindered further efforts on P A C T (Jori et al., 2006). 
With the outbreak of cases on the resistance of microbes towards antibiotics, 
there is an urge for alternative treatments. With the development of the more 
powerful and effective second generation photosensitizers, the potential of PDT on 
microbial treatment has been exploited again in the past few decades, which shows 
an abundance of promising results in viral (Rywkin et al.;, Semtana et al., 1994; 
Ben-Hur et al., 1995), bacterial (Wilson and Pratten, 1995) and fungal (Bertoloni et 
al., 1992) studies. 
Several advantages of using PACT draw the attention of scientists. First of 
all, PDT can be used for localized infections which do not need systemic treatment 
with antibiotics; this can minimize the chances of development of resistant strains 
and reduce the use of expensive antibiotics. Secondly, PACT mechanism of action is 
markedly different from those of antibiotic drugs, and so the efficacy is independent 
of the antibiotic resistance pattern of the microorganism. Thirdly, a single 
photosensitizer has a broad spectrum of action and acts against bacteria, fungi and 
protozoans. Also, it has low mutagenic potential and a lower chance of selection of 
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photoresistant strains. Moreover, the selectivity of the photosensitizer and the light 
may minimize the damage to the host tissue (Wainwright, 1998; Jori et al., 2006). 
1.3 Aim of present study 
Previous study has shown the photodynamic effects of a number of second 
generation photosensitizers, most of them being phthalocyanine derivatives. The 
latter chemicals have different substituents, giving them different hydrophobicity and 
different charges. One of the more active compounds amongst the latter is 
SiPc[C3H5(NMe2)20](OMe), an unsymmetrical bisamino substituted silicon(IV) 
phthalocyanine with a 1,3-bis(dimethylamino)-2-propoxy group and a methoxy 
group as the axial substituents, abbreviated as BAM-SiPc (Figure 1.4). 
A previous study has shown that BAM-SiPc is efficient in generating singlet 
oxygen (quantum yield = 0.26) and has a long excitation wavelength that peaks at 
674 nm (Lo et al., 2004). In vitro studies have also shown its potency against HepG2, 
HT29 and T84 cancer cells, and that it is selectively localized in the mitochondria 
(Lo et al” 2004; Lo et al., 2007a). Various phenomena, which include the loss of 
membrane asymmetry, D N A fragmentation and presence of TUNEL-positive cells, 
demonstrated that BAM-SiPc mediated PDT induces apoptosis in HepG2 cells (Lai 
et al., 2006). Recently, BAM-SiPc was successfully applied in an in vivo model, to 
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trigger tumor regression of HepG2 cells and, growth inhibition of HT29 cells in 
tumor bearing nude mice (Leung et al., 2008). 
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Figure 1.4 Chemical structure of BAM-SiPc. 
Although there are currently some studies about the photodynamic effect 
against microorganisms, the majority are limited to the traditional photosensitizers, 
such as Photofrin (Bliss et al., 2004), porphyrin (Lambrechts et al., 2005), toluidine 
blue O (TBO) (Paardekooper et al., 1995a) and methylene blue (de Souza et al., 
2006). Investigations of the new second generation photosensitizers on fungi are still 
limited, and the detailed mechanism of the photodynamic antifungal effect is far 
from being clear. Hence the possibility of using BAM-SiPc to photoinactivate C. 
albicans was evaluated and optimized in the present study. The phototoxic 
mechanisms involved, such as the uptake of the photosensitizers, the generation of 
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R O S and the membrane integrity after photodynamic treatment, were also studied. 
Apart from the planktonic model of C albicans, a biofilm model was also established 
to mimic the in vivo situation. The PDT effect of BAM-SiPc was then investigated. 
The viability, R O S production and photosensitizer distribution were studied in the 
biofilm system. 
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Chapter 2 
Materials and Methods 
2.1 Synthesis of BAM-SiPc 
The unsymmetrical bisamino silicon(IV) phthalocyanine, 
SiPc[C3H5(NMe2)20](OMe), abbreviated as BAM-SiPc, was kindly provided by Prof. 
Dennis K.P. Ng, Department of Chemistry, The Chinese University of Hong Kong. 
BAM-SiPc was synthesized according to the procedure described in Lo et al. (2004). 
M e O H was slowly added to a solution of SiPc[C3H5(NMe2)20] 2 in C H C I 3 . The 
bilayer system was allowed to stand under ambient condition for 3 days. The 
precipitate formed was filtered off and subjected to a basic alumina column (Merck, 
70-230 mesh A S T M ) developed with CHCb/hexane (1:2) as the eluent to give a 
greenish blue solid with Rf (CHCls/hexane 1:2) =0.86. 
2.2 Preparation of BAM-SiPc solution 
The solid BAM-SiPc was dissolved in distilled dimethylformamide (DMF) 
with sonication for 10 minutes. The concentration of the resulting solution was 
determined by measuring the absorbance at 674 nm in an Ultraspec 3000 UV/Visible 
spectrophotometer (Amersham Biosciences), using a molar absorptivity of 2.172 x 
106 for BAM-SiPc. The concentration was then adjusted to 800 jiM with 
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distilled D M F before further dilution to 80 |iM using an aqueous solvent of 
Cremophor EL (0.047 g/ml dHaO) which has been sterilized by filtering through 0.2-
}im-pore-size Aero disc® Syringe Filter. The 80 |iM solution was diluted to 
appropriate concentrations with phosphate buffered saline (PBS, 137 m M NaCl, 2.7 
m M KCl, 1.4 m M K H 2 P O 4 , 4.3 m M Na2HP04, pH 7.4). Acrodisc® Syringe Filters 
(0.2 |im) with Supor® Membrane were purchased from Pall Gelman Laboratory, 
USA. D M F and Cremophor EL were obtained from Sigma-Aldrich, USA. 
2.3 Yeast strains and culture conditions 
C. albicans strain ATCC® 18804 (Origin: human skin lesion of erosio 
interdigitalis, Uruguay) was obtained from American Type Culture Collection 
(ATCC) while the clinical isolate C. albicans 192887g (Origin: nasopharyngeal 
carcinoma patient) was kindly provided by Prof. L.P. Samaranayake, Oral 
Biosciences Laboratory, Faculty of Dentistry, The University of Hong Kong. 
Yeast mold (YM) broth (composed of 0.3 % of yeast extract (w/v), 0.3 % of 
malt extract (w/v), 0.5 % of peptone (w/v), 1% of dextrose (w/v)) was used for the 
culture. It was prepared by dissolving 21 g Y M broth powder in 1 L of ddHzO. Y M 
agar was prepared by dissolving Y M broth in ddH20 with the same concentration 
above and 2 % of agar (w/v). Both Y M broth and Y M agar were sterilized by 
autoclaving at 121 for 20 minutes. The Candida cells were maintained by re-
28 
Chapter 2 Materials and Methods 
Streaking on Y M agar every two to three weeks, and streaking from the glycerol 
stock at -80 every two months. To prepare the planktonic cells for PDT treatment, 
several colonies of C. albicans were picked and inoculated in 5 ml Y M broth in a 
pre-sterilized snap cap culture tube (17 x 100 mm). Cells were grown aerobically 
overnight at 30 with shaking at 250 rpm to stationary phase. The cells were then 
collected by centrifugation at 4,000 rpm, washed with PBS and resuspended in 5 ml 
fresh medium. Cells were then subcultured with 2 % of the overnight culture (1 ml 
cell suspension in 50 ml fresh Y M broth) in a conical flask to the exponential phase 
(〜4 X 10^  cells/ml, ODeoo ~ 1.0, confirmed by cell counting with a hemocytometer 
under a bright-field microscope), which took about 4 to 5 hours. The cells were then 
harvested, washed with PBS three times and adjusted to appropriate cell densities. 
The Y M broth powder was purchased from Difco, B D Diagnostic Systems, USA. 
The pre-sterilized snap cap culture tubes were products of Stockwell Scientific, USA. 
2.4 Light source 
The light irradiation for photodynamic treatment was generated from the 
Ceralas PDT 675 medical laser system (bandwidth 675 nm 士 3 nm, power range 
0.1 - 1 W ) coupled with a frontal light distributor. The medical laser system and the 
frontal light distributor were purchased from CeramOptec GmbH, a company of 
Biolitec group, Germany. 
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2.5 Assays of PDT with planktonic C. albicans 
2.5.1 Photodynamic treatment on planktonic cells 
Cell suspensions of density 10^ 10^  and 10^  cells/ml were incubated with 
BAM-SiPc at concentrations ranging from 0.0025 to 0.08 |iM at 30 in darkness 
for 1 hour with shaking at 250 rpm. Aliquots of 100 were then transferred into a 
96-well plate and illuminated at room temperature with a beam of PDT laser for 120 
seconds, the fluence rate was 0.1 Wcm'^ giving to a total fluence of 12 Jcm'^. Light, 
photosensitizer and solvent alone were used as controls and their toxicity was tested. 
The experiment was repeated with washing of cells (10^ cells/ml) with PBS three 
times before illumination. The density of cells after washing was estimated with 
spectrophotometer and adjusted to the same density before PDT treatment. 
To optimize the incubation time, the cells were pre-incubated with 0.02 jiM 
BAM-SiPc for different time periods, ranging from 0 to 60 minutes, before being 
illuminated for 120 seconds at 0.1 Wcm'^. To study the relationship between the 
light dose and the antifungal effect, the cells prepared were incubated with 0.02 jiM 
BAM-SiPc for 60 minutes. After that, a light dose ranging from 1.5 Jcm'^ to 48 
2 • • Jem' was applied. The dose was varied by changing the illumination period with a 
fixed fluence rate of 0.1 Wcm"^. 
The set-up for the photodynamic treatment on the planktonic cells is 
illustrated in Figure 2.1. The distance between the laser fibers and the bottom of the 
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96-well plate was fixed at 18 m m . The 96-well plate was covered with a lid during 
illumination in order to avoid contamination of the cell suspension. 
J 
‘. i .. I 
Figure 2.1 Set-up for the photodynamic treatment on the planktonic cells. 
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2.5.2 Clonogenic assay 
Viability of the planktonic cells was assessed by the clonogenic assay. Fifty 
jj,l of the cell suspension was diluted serially with 10- or 20-fold dilution to give 
〜200 to 300 colonies for the control. One hundred jil of the final diluted cell 
suspension was spread on Y M agar and incubated overnight at 30 The number of 
colony-forming units was counted and the survival percentage was calculated by 
comparison with the untreated control. The morphology of the colonies was also 
captured with the Multi-image light carbinet (Alphalmager 2200, Alpha Innotech 
corporation, USA). 
2.5.3 Cellular uptake of BAM-SiPc 
A standard curve of fluorescence reading versus the concentration of B A M -
SiPc in D M F was generated. To study the cellular uptake of BAM-SiPc, 1 ml of cell 
suspension (ICT cells/ml) was incubated with 0.8 fiM BAM-SiPc for different time 
periods. After the incubation, the cell suspensions were washed with 1 ml PBS three 
times by centrifugation at 7,000 rpm for 5 minutes each time. The cell pellets were 
then resuspended in 1 ml D M F and incubated overnight at 4 The cells were then 
spun down and the supernatants were collected for fluorescence measurement with a 
luminescence spectrophotometer (LS-50B, Perkin Elmer, USA). The excitation 
wavelength was set at 608 nm and the fluorescence emission spectrum was scanned 
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from 600 to 800 nm. The peak fluorescence intensity reading was recorded and the 
amount of BAM-SiPc in the supernatant was determined with reference to the 
standard curve. The number of photosensitizer molecule per cell was estimated by 
• • • • • 7 
dividing the amount of photosensitizer by the cell number of 10 . 
2.5.4 Distribution of BAM-SiPc in planktonic cells 
2.5.4.1 Fluorescence microscopic analyses 
Two ml of standardized cell suspension (10^ cells/ml) in PBS were seeded on 
a 25 m m circular microscope cover glass for 2 hours (for attachment) inside a 35 m m 
Falcon dish. The cell suspension was then removed and 8 juM BAM-SiPc was added 
for a further incubation of 1 hour. The coverslip was rinsed with PBS three times 
before being viewed under an Olympus IX 70 inverted microscope. The excitation 
light source at 630 nm was provided by a multiwavelength illuminator (Polychrome 
IV, TILL Photonics), and the emitted fluorescence signal at >660 nm was collected 
with a digital cooled C C D camera (Quantix, Photometries). The circular coverslips 
were products of Fisher Scientific, USA, and the Falcon dishes were products from 
B D Bioscience, France. 
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2.5.4.2 Confocal laser scanning microscopic (CLSM) analyses 
To visualize the distribution of BAM-SiPc, confocal microscopy was used. 
Cells prepared as above (10^ cells/ml) were first incubated with 0.08 |iM of B A M -
SiPc in darkness, then the cells were washed with PBS three times by centrifuging at 
7000 rpm to remove unbound or loosely bound photosensitizer. The cell suspension 
was added to a glass bottom confocal microwell dish and observed under a Leica 
SP5 confocal microscope. An argon laser of wavelength 633 nm was used for the 
excitation and the emission bandwidth was set from 650 nm to 750 nm. 
Simultaneously, transmitted light images were collected. The glass bottom confocal 
microwell dishes used were products of MatTek, USA. 
2.5.5 Determination of ROS level in planktonic cells 
The R O S level of the cells was determined by using 2' ,7' -dichlorofluorescein 
diacetate (DCFDA). A 1 m M D C F D A stock solution was prepared by dissolving 
solid D C F D A in 10% methanol and 90% PBS. The solution was freshly prepared or 
stored at 4 and used within one week. After the PDT treatment, 100 |il of the cell 
suspension was transferred into a microcentrigue tube and washed once with PBS. 
The cells were then resuspended with 100 |il D C F D A solution to give a final 
concentration of 100 [iM (by diluting the stock solution with PBS) and transferred to 
a 96-well plate. After 60-minute incubation in darkness, the fluorescence signal was 
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measured by a fluorescence plate reader (TECAN Polarion, Tecan U K Ltd, UK) with 
a 485 nm excitation filter and a 535 nm emission filter. The D C F D A powder was 
purchased from Molecular Probes, USA. 
2.5.6 Distribution of ROS in planktonic cells 
D C F D A was used together with the C L S M for visualizing ROS product 
formation. PDT treatment with 0.08 |iM was first performed on C. albicans at 10^  
cells/ml. The cells were then treated with the D C F D A solution as mentioned in 
Section 2.5.5, and the resulting cell suspension was transferred into a confocal 
microwell dish and visualized under a Leica SP5 confocal microscope. Lasers of 
wavelength 488 nm and 633 nm were used for the excitation of D C F D A and B A M -
SiPc respectively, while the fluorescence emission of bandwidth 500-600 nm was 
collected for D C F D A and 650-750 nm was collected for BAM-SiPc. Simultaneously, 
transmitted light images were captured. Control experiments of cells treated with 
0.08 BAM-SiPc without being illuminated and cells without any treatment were 
also conducted. 
2.5.7 Effect of ROS inhibitors 
Sodium azide, histidine and mannitol were used in order to study their effect 
on the PDT efficacy of BAM-SiPc. The three solutions were prepared by dissolving 
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the solid powder in PBS, which were then diluted to a final concentration of 4 m M , 
10 m M and 2.5 m M for histidine, mannitol and sodium azide, respectively. They 
were then added for co-incubation with 0.02 |iM BAM-SiPc and C. albicans (10^  
cells/ml). After 1 hour of incubation, the cell mixtures were subjected to the PDT 
treatment with an illumination of 0.1 Wcm'^ for 120 seconds. The cell viability was 
subsequently determined with the clonogenic assay. Sodium azide, histidine and 
mannitol were purchased from Sigma-Aldrich, USA. 
2.5.8 Membrane integrity assay 
Aliquots of 100 [i\ of cell suspension (10^  cells/ml) after photodynamic 
treatment were obtained and incubated at 30 for 1 hour to allow for recovery. 
Nine hundred |il of PBS and 2 |il of propidium iodide (PI, 2 mg/ml) were mixed and 
loaded into a 5 ml polystyrene round-bottom test tube, and 100 |il of cell suspension 
was added for staining. After 15 minutes, the fluorescence signal of the cells was 
analyzed by the FAS Canto Flow Cytometer (BD Biosciences, France). Cell 
populations with different intensities of fluorescence signal were then differentiated 
and the proportion was calculated with the use of the software WinMDI Version 2.9. 
PI (crystal form) was purchased from Sigma-Aldrich, USA, and the polystyrene 
tubes were purchased from B D Biosciences, France. 
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2.6 Assays of PDT with C. albicans biofilm 
2.6.1 Biofilm formation 
A colony of C. albicans (192887g) was picked and streaked onto a Y M agar 
plate, which was then incubated for 18-20 hours at 37 A freshly grown colony 
was inoculated into yeast nitrogen base (YNB) medium plus 50 m M glucose, which 
was then incubated for another 18-20 hours in an orbital shaker at 37 Cells from 
the overnight culture were washed three times with PBS. Cells were then 
resuspended in Y N B medium plus 100 m M glucose and adjusted to a cell density of 
1 X 10^  cells/ml ( O D 5 2 0 of 0.36-0.38). 
Biofilms were formed by adding 100 |il of the standardized cell suspension 
into the wells of a microliter plate (presterilized, polystyrene, flat-bottomed, 96-well 
microtiter plate). For cell adhesion, the microliter plate was incubated for 90 minutes 
at 37 with gentle shaking at 75 rpm. The unattached cells were then washed with 
PBS once and 200 [i\ Y N B medium plus 100 m M glucose were added and incubated 
at 37 with shaking at 75 rpm for different time periods (4 hours, 24 hours and 48 
hours). As a control, three wells of the 96-well plate were handled with the same 
condition, except that the standardized cell suspension was replaced with the Y N B 
medium, in order to check for any contamination. The wells without biofilm or 
control were also loaded with 200 jil PBS solution to reduce the evaporation and 
drying out of the medium. Y N B medium (lOX) was prepared by dissolving 1.34 g 
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Y N B powder in 20 ml ddHiO, mixed well and sterilize filtered with 0.2-|im-pore-
size Acrodisc® Syringe Filters. Glucose solutions of 50 m M and 100 m M 
concentrations were prepared by dissolving 1.8 g and 3.6 g glucose, respectively, in 
180 ml ddHzO and sterilized by autoclaving. Then the 20 ml lOX Y N B medium was 
mixed with the glucose solution. The Y N B medium was purchased from Difco, B D 
Diagnostic Systems, USA. D(+)-glucose was purchased from Sigma-Aldrich, USA. 
The 96-well plates were purchased from Iwaki, Japan. 
2.6.2 Photodynamic treatment on C. albicans biofilm 
After the biofilm of C. albicans isolate 192887g was prepared in 96-well 
plate, it was washed gently with 200 [i\ PBS. Different concentrations (0.15625 to 
20 |iM) of BAM-SiPc in 100 |il were added and the plate was wrapped with tin foil. 
The biofilms were incubated with the photosensitizer at 37 with shaking at 75 rpm 
for 1 hour. The biofilms were then illuminated with the diode laser with a fluence 
rate of 0.1 Wcm'^ for 120 seconds. The illumination set-up was the same as that 
shown in Figure 2.1. 
2.6.3 Viability assays 
2.6.3.1 XTT reduction assay 
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The X T T reduction assay was performed as described by Thein et al. (2007). 
The tetrazolium salt, 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) 
carbony 1]-2H-tetrazolium hydroxide (XTT), was first dissolved in PBS at a final 
concentration of 1 mg/ml. The solution was then sterilized by filtering through a 0.2-
|im-pore-size Aero disc® Syringe Filter and stored at -80 until use. Menadione 
was chosen as the electron-coupling agent and was freshly prepared before each 
assay. It was first dissolved in acetone at a concentration of 0.07 g/ml, and was then 
diluted at 10-fold twice with acetone. The XTT-menadione mixture was prepared at 
the ratio of PBS: XTT: menadione as 70:20:1 (v/v/v). 
The biofilm after the photodynamic treatment was post-incubated for 1 hour 
to allow for repair. It was then washed with 200 |il PBS once to remove the 
photosensitizer, and 200 of the XTT-menadione mixture was loaded to the wells 
and incubated for 3 hours at 37 in darkness. One hundred \x\ of the solution was 
then transferred to a new well to eliminate the background interference from the 
biofilm at the bottom. The absorbance reading at 490 nm of the solution was then 
measured with a microplate reader (Model 3550, Bio-Rad Laboratories, USA), and 
the reading of the well with XTT-menadione alone was used as blank. The 
percentage of cell viability was calculated as follow: 
OD490 of treated sample — O D 4 9 0 of blank 
Cell Viability (%) = x 100% 
O D 4 9 0 of control - O D 4 9 0 of blank 
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The X T T sodium salt and menadione crystalline were purchased from Sigma-Aldrich, 
USA. 
2.6.3.2 Molecular probes staining 
C. albicans isolate (192887g) was treated as above for biofilm formation. 
Two ml of the standardized cell suspension (10 cells/ml) in Y N B medium with 100 
m M glucose was loaded into the 12-well plate with 1 x 1 cm circular sterilized 
polystyrene coupons at the bottom to form the 24-hour and 48-hour biofilm. The 
coupon was then rinsed with PBS once and incubated with the BAM-SiPc solution 
for 1 hour and illuminated with the laser at 0.1 Wcm'^ for 120 seconds. The coupon 
after photodynamic treatment was incubated at 37°C for 1 hour and rinsed with PBS. 
After that, the biofilm was stained with the LIVE/DEAD BacLight Bacterial 
Viability kit, which is composed of SYTO-9 and PL SYTO-9 (3.34 m M ) and PI (20 
m M ) solution were mixed (1:1), then 3 [i\ of the dye mixture was added to each ml of 
PBS. Finally, 1 ml of the mixture was added into the wells and incubated for 20 
minutes at room temperature. The stained biofilm was then examined with a C L S M 
system (FLUOVIEW FV 1000, Olympus, Japan), where images of the single focal 
plane section of the stained biofilm were captured. The LIVE/ D E A D BacLight 
Bacterial Viability Kit was purchased from Molecular Probes, USA. The 12-well 
plates and the polystyrene coupons were products of Iwaki, Japan. 
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2.6.4 Determination of ROS level in biofilm 
The procedures for determining ROS level in biofilm were similar to those 
for planktonic cells (Section 2.5.5). The photosensitizer solution was discarded from 
the 96-well plate right after the photodynamic treatment. The biofilms were gently 
washed with PBS once. One hundred |il D C F D A (100 |iM) was added to each well. 
The plate was then incubated for 60 minutes at 37 in darkness. The fluorescence 
signal at 535nm was measured by a fluorescence plate reader. 
2.6.5 Distribution of BAM-SiPc in biofilm 
C. albicans isolate (192887g) was treated as mentioned above (Section 2.6.1) 
for biofilm formation. Two ml of the cell suspension in Y N B medium with 100 m M 
glucose was then loaded onto the glass bottom confocal microwell dish and 
incubated at 37 °C with shaking at 40-50 rpm, which was slower than the one for 
biofilm in 96-well plate to avoid excessive shearing force. After 90 minutes, the 
confocal dish was washed once with 2 ml of PBS, which was then reloaded with 2 ml 
fresh Y N B medium plus 100 m M glucose. After incubation at 37 with shaking of 
40-50 rpm for 48 hours, the biofilm was washed once with PBS. Two ml of B A M -
SiPc (0.8 jiM) was added and incubated for 1 hour in darkness. The biofilm was then 
washed with PBS three times to remove the unbound or loosely bound 
photosensitizers, and the confocal dish was observed under a Leica SP5 confocal 
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microscope with the setting as mentioned in Section 2.5.4.2. In addition to the single 
focal plane sections, the biofilm was sectioned from top to the bottom and the three-
dimensional image was reconstructed 
2.6.6 Photodynamic treatment on C. albicans from resuspended biofilm 
Forty eight-hour biofilms were formed on the 96-well plate and washed once 
with 200 |il PBS. One hundred |il PBS was then added to each well and the biofilms 
were scraped with autoclaved pipette tips. The cell suspensions were collected and 
washed with PBS three times by centrifugation at 7000 rpm. The cell density was 
then determined with the use of a hemocytometer and adjusted to a final density of 
10^ cells/ml. The resuspended cells were incubated with different concentrations of 
BAM-SiPc ranging from 0.01 to 0.32 |LIM at 37 with shaking for 1 hour in 
darkness. The PDT treatment was the same as the one for planktonic cells A T C C 
18804. Cell viability was determined by the clonogenic assay. 
2.7 Statistical analysis 
Data were expressed as mean 士 standard error of mean (SEM). Statistical 
analysis was performed by using the Student's t-test. A p value of < 0.05 was 
considered as statistically significant. 
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Chapter 3 
Results 
3.1 BAM-SiPc mediated PDT on planktonic C. albicans 
3.1.1 Antifungal effect of BAM-SiPc on C. albicans 
3.1.1.1 PDT activities on different strains of C. albicans 
The photodynamic antifungal effect of BAM-SiPc was studied by using C. 
albicans as the target pathogen. Both C. albicans A T C C 18804 and 192887g were 
susceptible towards the photodynamic treatment of BAM-SiPc in a dose-dependent 
manner (Figure 3.1). The susceptibilities of the two strains were similar as shown by 
the IC50 values: 0.011 ^ iM and 0.048 |iM for A T C C 18804 and 192887g respectively. 
No dark toxicity was observed for both strains at or below 0.08 |LIM of BAM-SiPc. 
Illumination alone in the absence of BAM-SiPc did not induce any cytotoxicity 
(Table 3.1). The results indicate that the antifungal effect was present only when 
both the PS and light were applied on the cells together. 
The cell viability was assessed by the clonogenic assay. The number of 
colony was counted after overnight incubation. Not only was the number of colony 
on the agar plate decreased after PDT treatment, the size of the colonies was also 
smaller when compared with the untreated one (Figure 3.2). 
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Table 3.1 Different controls for the PACT assay on planktonic C. albicans 
Cell viability (%) 
Candida Strain 
Light control Dark control Solvent control 
A T C C 18804 103.2 ± 14.7 104.6± 11.0 95.5 ± 0.2 ** 
192887g 83.5 ±8.3 103.6 ± 3.2 90.3 土 14.8 
Light control: cells illuminated with laser at 0.1 Wcm'^ for 120 seconds in the 
absence of BAM-SiPc; Dark control: cells incubated with BAM-SiPc at 0.08 |iM for 
1 hour without illumination; Solvent control: cells pre-incubated with 0.0047g/ml 
Cremophor EL in PBS and illuminated at 0.1 Wcm'^ for 120 seconds. The viability 
was determined by the clonogenic assay. Each data represents the mean 士 SEM, n = 
4 for A T C C 18804, n = 2 for 192887g, each performed in duplicate. **, p < 0.005 
when compared with the one with no treatment. 
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Figure 3.1 Antifungal effect of BAM-SiPc on different strains of C. albicans. 
The cells (10^ cells/ml) were pre-incubated with BAM-SiPc for 1 hour and irradiated 
at 0.1 Wcm-2 for 120 seconds. Cell viability was determined with the clonogenic 
assay. C. albicans A T C C 18804; •: C. albicans 192887g. Each data point 
represents the mean 士 SEM, n = 4 for A T C C 18804, n = 2 for 192887g, each 
performed in duplicate. *, p < 0.05 and **, p < 0.005 when compared with dark 
control. 
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Figure 3.2 Morphology of the photodynamically treated C. albicans after 
overnight incubation, (a) Control with no treatment (b) photodynamically treated 
with 0.02 |iM BAM-SiPc and a light dose of 12 Jcm'l In both cases the dilution 
before plating was the same. 
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3.1.1.2 Effect of different densities of cells 
To study the relationship between the density of the Candida cells and the 
susceptibility towards the photosensitizer BAM-SiPc, PDT was performed by using 
different densities (lO。，lO? and 10^  cells/ml) of A T C C 18804 cells. The result is 
shown in Figure 3.3. Photodynamic treatment with BAM-SiPc produced an 
antifungal effect in a dose-dependent manner in all the three cases. The I C 5 0 values 
for cell density of lO。，lO? and 10^  cells/ml were 0.005, 0.013 and 0.074 
respectively. Thus, there was a decrease in cytotoxicity when the density of cells 
increased. 
3.1.1.3 Effect of a washing step before illumination 
In the assays described above, the cells were incubated with the 
photosensitizer and illuminated without washing away the unbound photosensitzer. 
In order to eliminate the effect of the BAM-SiPc in solution and those loosely bound 
to the cells, experiments were performed with cells that were washed with PBS three 
times after the incubation and prior to the illumination. Figure 3.4 shows that after 
washing away the photosensitizer in solution (or loosely bound on the cells), the 
treatment was still effective, though there was a decrease in the potency of 
inactivation of C. albicans. The I C 5 0 was 0.029 |iM, which was about 2-3 fold 
higher than that without the washing step. 
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Figure 3.3 Photodynamic effect of BAM-SiPc on C. albicans at different cell 
6 7 8 
densities. Suspensions with a cell density of 10 (•), 10 (•), and 10 (•) cells/ml 
were incubated with different concentrations of BAM-SiPc at 30 for 1 hour. After 
illumination with a fluence rate of 0.1 Wcm"^ for 120 seconds (total fluence of 12 
Jcm-2)，the cell viability was determined by the clonogenic assay. Each data point 
represents the mean 士 S E M from three independent experiments, each performed in 
duplicate. *, p < 0.05 and p < 0.005 when compared with dark control. 
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Figure 3.4 Photodynamic effect of BAM-SiPc on C. albicans with a washing step 
before illumination. Cell suspensions of 10^  cells/ml were washed with PBS three 
times after incubation with BAM-SiPc at 30 ^ C for 1 hour. After illumination with a 
fluence rate of 0.1 Wcm'^ for 120 seconds (total fluence of 12 Jcm'^ ), the cell 
viability was determined by the clonogenic assay. •: with washing before 
illumination; •: without washing before illumination. Each data point represents the 
mean 士 S E M from three independent experiments, each performed in duplicate. *, 
p < 0.05 and **, p < 0.005 when compared with dark control. 
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3.1.2 Optimization of PDT conditions with BAM-SiPc on C. albicans 
3.1.2.1 Time course study 
Different durations of pre-incubation may cause variations in the antifungal 
effect of the PDT treatment, and the effect may vary significantly for different 
interactions between the photosensitizer and the cell, for example, those being taken 
up into the cell may take a longer time to exert the effect than those bound outside 
the cell. Moreover, it would be more valuable for clinical use if the photosensitizer 
could show an antifungal effect with a shorter pre-incubation time. A time course 
study of pre-incubation time was thus performed. BAM-SiPc of 0.02 |iM was used 
with the illumination fixed at 0.1 Wcm'^ for 120 seconds. Figure 3.5 shows that an 
incubation time of 5 to 15 minutes was already sufficient to exhibit the optimal 
antifungal effect. 
3.1.2.2 Light dose study 
In order to change the light dose, two parameters may be varied, viz., the 
fluence rate and the duration of illumination. In the present experiment, the light 
dose was changed by varying the duration of illumination from 15 seconds to 480 
seconds with a constant fluence rate of 0.1 Wcm"^. The result indicated that there 
was an increase in cytotoxic effect when a higher light dose was used (Figure 3.6). 
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Figure 3.5 Time-course study of antifungal effect of BAM-SiPc on C. albicans. 
Cells (107 cells/ml) were pre-incubated with 0.02 |iM BAM-SiPc for different time 
periods before being irradiated at 0.1 Wcm'^ for 120 seconds. Cell viability was 
determined with the clonogenic assay. Each data point represents the mean 土 S E M 
from four independent experiments, each performed in duplicate. p < 0.005 
when compared with dark control. 
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Figure 3.6 Light dose study of antifungal effect of BAM-SiPc on C. albicans. 
Cells (10^ cells/ml) were pre-incubated with 0.02 |iM BAM-SiPc for 1 hour before 
being irradiated at 0.1 Wcm'^ for time periods ranging from 15 to 480 seconds. Cell 
viability was determined with the clonogenic assay. Each data point represents the 
mean 士 S E M from two independent experiments, each performed in duplicate. p 
< 0.005 when compared with dark control. 
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3.1.3 Uptake of BAM-SiPc 
Solvent extraction was performed for the analysis of the amount of B A M -
SiPc taken up by C. albicans. In order to obtain a high, reliable fluorescence reading, 
0.8 (iM BAM-SiPc was chosen as the drug concentration for pre-incubation. The 
standard curve of fluorescence signal of BAM-SiPc in D M F is shown in Figure 3.7. 
A time course study showed that the amount of BAM-SiPc uptaken had a continuous 
increase up to 5 hours and the fastest uptake was within the first 30 minutes (Figure 
3.8). 
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Figure 3.7 Standard curve of the fluorescence of BAM-SiPc in DMF. Different 
concentrations of BAM-SiPc ranging from 0.01 to 1.6 |iM were prepared in DMF. 
The excitation wavelength was set at 608 nm and the fluorescence intensity at the 
peak 674 nm was recorded. 
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Figure 3.8 Time course study of the amount of BAM-SiPc uptake. C. albicans 
were incubated with 0.8 \xM BAM-SiPc for different durations. The cells were then 
washed thrice with PBS and organic extraction with D M F was performed. The 
fluorescence reading of the organic solvent was measured with a luminescence 
spectrophotometer. Each data point represents the mean 士 S E M from three 
independent experiments, each performed in duplicate. 
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3.1.4 Distribution of BAM-SiPc in the planktonic cells 
3.1.4.1 Analysis with fluorescence microscopy 
To determine whether there is any interaction between BAM-SiPc and C. 
albicans, the cells were incubated with BAM-SiPc, which is fluorescent by itself, and 
observed under the fluorescence microscope. With the washing away of the unbound 
and loosely bound BAM-SiPc, the remaining fluorescent signal should come from 
the photosensitizers that were tightly bound outside the cells or those taken up into 
the cells. A strong fluorescence signal was observed after the washing process 
(Figure 3.9), suggesting that there was a tight interaction between the cells and 
photosensitizers or they were taken up. 
3.1.4.2 Analysis with CLSM 
The results from the fluorescence microscope are not sufficient to 
differentiate whether the photosensitizers are inside or outside the cells. This can be 
solved with the help of CSLM. After the unbound and loosely bound BAM-SiPc had 
been washed away, the fluorescence signal from BAM-SiPc was observed to be 
distributed throughout the entire cell (Figure 3.10) with some relatively stronger 
signals in the organelle. This demonstrates the effective cellular uptake of the 
photosensitizer. 
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Figure 3.9 Fluorescence microscopic images of planktonic C. albicans. Cells 
were incubated with 8 )iM BAM-SiPc for 1 hour in the dark. Cells were then rinsed 
with PBS three times and observed under a fluorescence microscope. (a) 
Fluorescence image and (b) Bright field image. 
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Figure 3.10 CLSM images of planktonic C, albicans. Cells were incubated with 
0.08 i^M BAM-SiPc for 1 hour in the dark. After washing with PBS three times, the 
cells were observed under a confocal microscope, (a) Fluorescence image and (b) 
Bright field image. 
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3.1.5 ROS production upon PDT treatment 
3.1.5.1 ROS level in the planktonic cells 
It is the principal concept for the mechanism of PDT that R O S is generated 
when the photosensitizers are illuminated with the corresponding light, which 
eventually causes cell damage. In order to gain more insight into the mechanism of 
how BAM-SiPc induces cell damage, D C F D A was used for the determination of the 
intracellular R O S level. A dose-dependent correlation was observed between B A M -
SiPc concentration and the generated ROS level (Figure 3.11). At 0.08 |iM B A M -
SiPc, the R O S level was about 3.5 fold higher than that of the control. In the absence 
of light illumination, BAM-SiPc treatment did not have any major effect on ROS 
generation (93 士 1.4 o/o). 
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Figure 3.11 BAM-SiPc-induced production of ROS in C. albicans. The cells 
were incubated with different concentrations of BAM-SiPc. After the illumination, 
the cells were washed once with PBS and incubated with 100 |iM D C F D A solution 
for 1 hour in the dark. Fluorescence signal was measured by using a fluorescence 
plate reader with 485 nm excitation and 535 nm emission filters. Each data point 
represents the mean 士 S E M from three independent experiments, each performed in 
duplicate. p < 0.005 when compared with dark control. 
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3.1.5.2 Distribution of ROS production 
In order to investigate the distribution of ROS produced inside the cells after 
treatment with BAM-SiPc，DCFDA was used together with a confocal laser scanning 
microscope. The confocal images (Figure 3.12a) showed that the fluorescence signal 
from D C F D A was dispersed over the entire cell after illumination of the cells treated 
with BAM-SiPc. In contrast, the ROS signal was much weaker and localized for 
control cells kept in the dark (Figure 3.12b) and cells without any treatment (Figure 
3.12c). It suggests that the ROS generated was distributed more or less evenly over 
the cells after PDT with BAM-SiPc. 
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Figure 3.12 Confocal microscopic images in the DCFDA assay of BAM-SiPc 
PDT-treated C. albicans, PDT treatment of 0.08 [lM BAM-SiPc was performed on 
C. albicans and D C F D A assay was performed. The fluorescence images were 
captured with the confocal microscope. An objective of 63X water lens was used 
and the zoom was set as 4X. (a) Cells with BAM-SiPc and illumination; (b) Dark 
control of cells with BAM-SiPc; (c) Dark control of cells without any treatment. 
(Left) Fluorescence images of DCFDA; (Middle) Fluorescence images of BAM-SiPc; 
(Right) Bright field images of C. albicans. The data shown are representatives from 
two independent experiments. 
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3.1.5.3 Effect of different ROS inhibitors on BAM-SiPc's potency 
During the activation of BAM-SiPc, there are a variety of R O S generated. 
Some common R O S inhibitors, for example, sodium azide, histidine and mannitol, 
were chosen and used to study the contribution of different kinds of ROS in causing 
cell death. Sodium azide and histidine are known as scavengers of singlet oxygen 
and mannitol is a scavenger of hydroxyl radicals. Histidine (4mM), mannitol (10 
m M ) and sodium azide (2.5 m M ) were added together with BAM-SiPc prior to the 
illumination, and the resulting cell viabilities are shown in Figure 3.13. The cell 
viability was reduced to -30 - 40 % upon treatment with 0.02 |iM BAM-SiPc. The 
cytotoxic effect was completely inhibited when 4 m M histidine was added. However, 
addition of mannitol or sodium azide did not show any inhibitory effect on the 
cytotoxicity. Control of the three scavengers were also performed. None of them 
showed any effect on the viability of C. albicans cells when added alone to the cell 
without photodynamic treatment. 
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Figure 3.13 Inhibitory effect of different ROS scavengers on the efficacy of 
BAM-SiPc. Histidine (4 mM), mannitol (10 m M ) or sodium azide (2.5 m M ) was 
added together with 0.02 jiM BAM-SiPc for pre-incubation of 1 hour before 
illumination at 0.1 Wcm'^ for 120 seconds. Control experiments with the three 
scavengers alone were also included. Shaded bars: With 0.02 |iM BAM-SiPc and 
illumination; Striped bars: Without BAM-SiPc and no illumination; Open bar: Dark 
control with 0.02 ^ iM BAM-SiPc but no illumination. Each data point represents the 
mean 士 S E M from three independent experiments, each performed in duplicate. **, 
p < 0.005 when compared to the one with photodynamic treatment with 0.02 ^ iM 
BAM-SiPc. 
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3.1.6 Membrane integrity 
PI staining was used to investigate whether there is any alteration in 
membrane integrity. C. albicans cells in all the three controls, viz. dark control 
(Figure 3.14A-h), light control (Figure 3.14A-a), and no treatment control (Figure 
3.14A-i), showed a low level of fluorescence, indicating that the membrane was 
intact preventing PI from entering the cell. Figures 3.14A(a-g), show a gradual shift 
of cell population from the low fluorescence level on the left to the high fluorescence 
level on the right. The photodynamic treatment showed a dose-dependent increase in 
the fluorescence level (Figure 3.14B). The whole cell population became permeable 
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Figure 3.14 BAM-SiPc-induced cell membrane damage in C. albicans, (A) After 
photodynamic treatment of the cells with different concentrations [(a) 0 |iM, (b) 
0.0025 |iM, (c) 0.005 |iM, (d) 0.01 |iM, (e) 0.02 jiM, (f) 0.04 [iM and (g) 0.08 jiM] of 
BAM-SiPc, the cells were stained with PI and the fluorescence signal was analyzed 
by using a flow cytometer. Besides (a) which was the light control, two more 
controls, (h) dark control with 0.08 |iM BAM-SiPc and (i) no treatment control, were 
performed. The data shown are representatives from three independent experiments. 
(B) The membrane integrity curve after the cells were treated with different 
concentrations of BAM-SiPc. Each data point represents the mean 士 SD from three 
independent experiments. *, p < 0.05 and p < 0.005 when compared with dark 
control. 
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3.2 BAM-SiPc mediated PDT on C. albicans biofilm 
3.2.1 Establishment of the biofilm model with 192887g 
The cell suspension of C. albicans isolate 192887g was used at different cell 
densities for the initial attachment in order to optimize and determine the most 
suitable cell density for the formation of robust biofilm. The X T T assay was used to 
determine the amount of biofilm formed. Among the cell densities examined (from 
10^  to 10^  cells/ml), the 48-hour biofilm formed with a suspension of 1 x 10^  cells/ml 
for the adhesion phase was the most robust (Figure 3.15). The biofilm of all cell 
densities used showed a greater viability for the group with washing after the 
adhesion phase for the initial 90 minutes than the one without washing. C. albicans 
A T C C 18804 was also tested for the formation of a biofilm. However, no biofilm 
was formed successfully. A biofilm of 192887g was formed successfully with white 
robust cells on the polystyrene plate (Figure 3.16) and attached tightly even after 
washing with PBS. 
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Figure 3.15 Formation of 48-hour biofilm with different cell densities of C, 
albicans. Cell densities of 10^  to ICT cells/ml were used for the initial adhesion 
phase of biofilm. One hundred |il of standardized cell suspensions of different 
densities were added to a 96-well plate. After the 90-minute attachment, the biofilm 
was either washed with PBS once or proceeded without washing. The 48-hour 
biofilm formed was then assessed with the X T T assay. Each data point represents 
the mean 士 S E M from two independent experiments, each performed in 
quadruplicate. 
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Figure 3.16 Morphology of the 48-hour biofilm of C. albicans 192887g on a 96-
well plate. (Upper row) Control with Y N B medium plus 100 m M glucose without C. 
albicans., (Lower row) 48-hour biofilm of C. albicans 192887g. 
71 
Chapter 3 Results 
3.2.2 Photodynamic treatment on 192887g biofilm 
3.2.2.1 Viability assay - XTT assay 
Photodynamic treatments were performed to investigate the potency of B A M -
SiPc on killing C. albicans in the biofilm form. The 24-hour and 48-hour biofilms 
were used and cell viability was determined by the X T T reduction assays. There was 
only a minor cytotoxic effect on the 24-hour and 48-hour Candida biofilm in both 
the dark control as well as the one with illumination (Figure 3.17). At least 70 % of 
cells remained viable when a high concentration of 20 |iM BAM-SiPc was used. 
3.2.2.2 Viability assay - LIVE/DEAD BacLight Bacterial Viability kit 
The molecular probe SYTO-9 is a small green fluorescent dye that can stain 
both live and dead cells while PI can only stain cells with a damaged membrane. In 
order to distinguish live and dead cells, a combination of SYTO-9 and PI was used to 
stain the biofilm after PDT with BAM-SiPc. Figure 3.18a and Figure 3.18c show the 
fluorescence from SYTO-9 in the 24-hour and 48-hour biofilm, respectively, after 
photodynamic treatment with 20 |iM BAM-SiPc. A complex biofilm structure with 
both blastospore and hypae could be observed in both biofilms. However, a 
relatively low proportion of cells were stained by PI in both the 24-hour (Figure 
3.18b) and 48-hour biofilm (Figure 3.18d), indicating that the majority of cells in the 
biofilm remained viable after photodynamic treatment with BAM-SiPc. 
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Figure 3.17 Effect of photodynamic treatment of BAM-SiPc on cell viability in 
C. albicans biofilm. Twenty-four-hour (•) and 48-hour (•) biofilms of strain 
192887g were formed on the 96-well plate. After incubation of the cells with B A M -
SiPc for 1 hour, light of of 0.1 Wcm_ was applied for 120 seconds with the laser 
system. X T T reduction assay was performed after a recovery period of 1 hour. Each 
data point represents the mean 士 S E M from three independent experiments, each 
performed in duplicate. p < 0.05 and p < 0.005 when compared with dark 
control. 
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Figure 3.18 Confocal microscopic images of SYTO-9 and PI staining of C 
albicans biofilm after photodynamic treatment with BAM-SiPc. Biofilms were 
formed on the polystyrene coupons and 20 |iM of BAM-SiPc was used for the 
photodynamic treatment. The biofilm was stained with the LIVE/DEAD BacLight 
Bacterial Viability kit. (a) 24-hour biofilm, SYTO-9; (b) 24-hour biofilm, PI; (c) 48-
hour boifilm，SYTO-9; (d) 48-hour biofilm, PL 
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3.2.3 ROS level in the biofilm after PDT treatment 
D C F D A was used for the determination of R O S production in the biofilm 
after PDT with BAM-SiPc. Forty-eight-hour biofilm was formed and treated with 
different concentrations of BAM-SiPc. A maximum of 2-fold R O S level was 
observed between the doses ranging from 0.04 to 20 |iM (Figure 3.19). ROS 
production was weaker than that observed in the planktonic cells. For example, at 
0.08 jiM BAM-SiPc, there was a 〜3.5-fold increase in R O S production in planktonic 
C. albicans (Figure 3.11) while there was only a 〜1.2-fold increase in ROS level in 
the biofilm model. 
3.2.4 Distribution of BAM-SiPc in the biofilm 
C L S M was used for investigation of the distribution and uptake of BAM-SiPc 
of cells in the biofilm form. There was a strong intracellular fluorescence signal in 
the yeast in the biofilm even after thorough washing of BAM-SiPc (Figure 3.20), 
demonstrating the presence of cellular uptake of the photosensitizer. Different 
confocal plane sections of the biofilm were also captured for the 3D re-construction 
(Figure 3.21), which showed that the cellular uptake of BAM-SiPc occurred 
throughout the whole population of the biofilm. 
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Figure 3.19 Intracellular ROS production in C. albicans biofilm after 
photodynamic treatment with BAM-SiPc. Forty-eight-hour biofilms were 
incubated with different concentrations of BAM-SiPc for 1 hour, which were then 
illuminated at 0.1 Wcm"^ for 120 seconds. Assay with D C F D A solution was 
performed after the illumination (•) and the fluorescence signal was measured with 
a fluorescence plate reader. Control experiment without illumination (•) was also 
performed. Each data point represents the mean 士 S E M from two independent 
experiments, each performed in duplicate. *，p < 0.05 when compared with dark 
control. 
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Figure 3.20 Uptake of BAM-SiPc by C. albicans cells in the biofilm system. 
Biofilm of 48-hour was incubated with 0.8 |iM BAM-SiPc for 1 hour in the dark. 
Single confocal plane image was captured after thorough washing with PBS three 
times, (a) Fluorescence image from BAM-SiPc; (b) Bright field image. 
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Figure 3.21 Uptake of BAM-SiPc by C albicans cells in the biofilm system (a 
reconstructed 3D image). Biofilm of 48-hour was incubated with 0.8 jaM B A M -
SiPc for 1 hour in the dark. 3D images of (a) the fluorescence signal from B A M -
SiPc and (b) the bright field image were re-constructed from the confocal plane 
images from different sections. The data shown are representatives from two 
independent experiments. 
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3.2.5 Photodynamic treatment on C. albicans from resuspended biofilm 
Candida cells of the biofilm were resuspended in PBS in order to investigate 
their susceptibility towards PDT with BAM-SiPc. The resulting cell suspension was 
treated under the same conditions used for the P A C T of planktonic C. albicans. 
Survival curve determined with the clonogenic assay indicates that the photodynamic 
activity of BAM-SiPc was effective with a dose-dependent trend and the I C 5 0 was 
0.03 iiM (Figure 3.22). 
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Figure 3.22 Effect of photodynamic treatment of BAM-SiPc on C. albicans 
resuspended from the biofilm. Cells in 48-hour biofilm were scraped and 
resuspended in PBS. The resulting cell suspension was adjusted to a cell density of 
10^  cells/ml and subjected to PDT with BAM-SiPc. The viability was determined 
with the clonogenic assay. Each data point represents the mean 士 S E M from two 
independent experiments, each performed in duplicate. p < 0.05 and p < 0.005 
when compared with dark control. 
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Chapter 4 
Discussion 
In an attempt to combat the outbreak of antibiotic-resistant microbial 
pathogens, investigations of PDT (or PACT) are currently in progress. In fact PDT 
is a potent technique that may kill a variety of undesirable living cells. Nevertheless, 
its antimicrobial effect, which was discovered over a hundred years ago, has been 
largely ignored. Phthalocyanines, a second generation photosensitizers, are capable 
of being modified with different central ligands and side chains in order to enhance 
their photodynamic potency. A derivative of phthalocyanine, BAM-SiPc, was shown 
to be effective in treating cancer (Lo et al., 2004; Lai et al., 2006, Lo et al., 2007a; 
Leung et al., 2008). The potency of BAM-SiPc and its antifungal activity against a 
common human pathogen, C. albicans, was evaluated in the present study. 
4.1 Antifungal effect of BAM-SiPc on the planktonic C. albicans 
The antifungal potency of BAM-SiPc was first studied, and the effect was 
noted to be dose-dependent. The I C 5 0 values for the two C. albicans strains used 
were both at sub-micro molar level, which were 0.011 and 0.048 |liM at a total 
fluence of 12 Jcm"^. No dark toxicity was observed in the control experiments. 
When compared with some typical photosensitizers, like porphyrin (e.g. Photofrin) 
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and phenothiazine dye (e.g. methylene blue and toluidine bue), BAM-SiPc seems to 
be more potent. For example, Bliss et al (2004) demonstrated that there was a 
reduction of 50 % viability of C. albicans with the use of 0.3 |ag/ml Photofrin (〜 
0.254 ^ iM) and a fluence of 9 Jcm'l Fifty |iM T B O (Demidova and Hamblin, 2005) 
and 0.1 mg/ml (〜313 jiM) of methylene blue (Zeina et al., 2001) were reported to be 
used for the destruction of C. albicans. The effective concentrations of these typical 
photosensitizers are 20-fold to 10,000-fold greater than that of BAM-SiPc. 
Interestingly, another research performed by Jackson et al. (1999) demonstrated that 
the killing effect of T B O is not dose-dependent and paradoxically a high dose of 
photosensitizer results in a lower efficiency. This phenomenon was explained by the 
saturated target sites and activation of unbound photosensitizers; the ROS generated 
might be quenched before causing the damage. Since it is obvious that BAM-SiPc 
has the potential to serve as an antifungal photosensitizer, further investigations were 
carried out. 
Cell density is an important factor usually overlooked during the assessment 
of the degree of cell susceptibility upon PACT. Our result showed that the 
susceptibility of C. albicans was inversely related to the cell density. Higher cell 
densities led to less killing. This may be partly due to the competitive inhibition of 
the available photosensitizer and ROS by the increasing mass of cells. Demidova 
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and Hamblin (2005) have suggested that a high dependence on the cell density may 
reflect the strength and avidity of the binding of the photosensitizer to the cells. 
It is obvious that PDT of BAM-SiPc showed a fungicidal effect rather than a 
fungistatic effect, while some of the antibiotics used currently, such as fluconazole, 
are just fungistatic in nature (Hitchcock, 1993). Nevertheless, the colonies formed 
by the remaining survived C. albicans cells appeared to have a reduced diameter, 
which demonstrated a growth-inhibiting or growth-delay effect of the BAM-SiPc 
mediated PDT. A similar phenomenon has also been reported when A L A was used 
for the photo-inactivation of Trichophyton rubrum (Kamp et al., 2005). 
4.2 Effects of different conditions on the photodynamic treatment 
with BAM-SiPc 
The efficacy of PDT depends on many factors, which include the type of 
photosensitizer, the concentration and its intracellular localization, the oxygen 
availability, light dose and dose rate, etc. In view of the antifungal potency of B A M -
SiPc, fine adjustment of the conditions for treatment is necessary. A successful PDT 
should maximize the difference between the cytotoxicity against the target cells and 
that against the host (Maisch et al., 2005). 
One solution to minimize the toxicity to the host is to reduce the exposure 
time to the photosensitizer. The time-course study performed indicates that a pre-
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incubation time of 5 to 15 minutes was sufficient for BAM-SiPc to exert its 
antifungal effect on C. albicans., further increase in the pre-incubation time did not 
appreciably increase its potency. In this regard, it is similar to previous observations 
on other photosensitizers against C. albicans (2-5 minutes for T B O and 1 minute for 
Trip[4]) (Jackson et al., 1999; Lambrechts et al., 2005). The short incubation time is 
beneficial as it can minimize the uptake of BAM-SiPc in human cells and reduce the 
cytotoxicity. 
The PDT standard assays were performed without washing the 
photosensitizer prior to illumination. This was performed in order to avoid the 
washing away of cells which would cause a variation in cell number and then the 
subsequent need to re-standardize the cell density. However, the photosensitizers 
suspended in the solution may also be photoactivated and generate ROS to produce a 
cytotoxic effect. Addition of a washing step before illumination decreased the 
potency of BAM-SiPc on C. albicans by 2- to 3-fold. Though the washing away of 
the unbound and loosely bound photosensitizers decreased the potency, it was still 
very effective for the BAM-SiPc treatment. In the study of Lambrechts et al. (2005), 
washing of cells prior to illumination abolishes the antifungal effect of the cationic 
porphyrin TriP[4] completely. A similar effect is present in the PDT with TBO. 
These results imply that the photosensitizers in solution play an active role in the 
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photo-inactivation for TriP[4] and TBO, while the cytotoxicity induced by the 
intracellular photosensitizer was more important for BAM-SiPc. 
Light dose and photosensitizer concentration are two critical factors that 
determine the extent of the killing effect. Diode laser was employed as the light 
source in the present study to reduce the unfavorable thermal effect. The specific 
wavelength of the laser (675 nm 士 3 nm) hits the peak of the absorption spectrum of 
BAM-SiPc (674 nm). As a result, the light dose delivered can be calculated more 
accurately. Although the same light dose can be provided with different 
combinations of fluence rate and duration of illumination, their effect may be 
different. One reason is that some extracellular photosensitizers may influx into the 
cell when illumination starts, then the influx photosensitizers may have more time for 
causing intracellular oxidative damage with a longer illumination time. There was a 
direct relationship between the light dose and the phototoxicity in C. albicans with 
BAM-SiPc, as in many other studies (Foley et al., 2006; Tegos et al., 2006; 
Mantareva et al., 2007). In order to compromise the balance between the 
illumination time and photosensitizer concentration, a total fluence of 12 Jcm'^ at 0.1 
Wcm-2 was chosen. Recently, the possibility of using alternative light source arose 
in order to replace the expensive laser, for example, Peloi et al. (2008) reported a 
successful case of using a LED to perform antifungal treatment with methylene blue. 
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4.3 Mechanistic study of the antifungal effect of BAM-SiPc 
Unlike the use of PDT in cancer where the detailed mechanism of the cell 
death pathways (e.g. the apoptosis and necrosis pathways) has been intensively 
studied and published (Plaetzer et al., 2005; Buytaert et al., 2007), the studies of 
PDT for antifungal use are still in its infancy. Research on PACT and the newly 
developed photosensitizers have been mainly focused on the screening of the broad-
spectrum effect on different microbes, including gram positive bacteria, gram 
negative bacteria and C. albicans (Toley et al., 2006; Mantareva et al., 2007; Peloi et 
al., 2008). There are only limited studies on the mechanisms of antigungal PDT, 
using the typical photosensitizers, such as Photofrin, methylene blue and toluidine 
blue (Paardekooper et al., 1995a; Bliss et al., 2004; Giroldo, 2007). To fill this void, 
the interactions and the death mechanisms of PDT were investigated. 
4.3.1 Interaction between BAM-SiPc and C. albicans 
It is beneficial that most photosensitizers emit fluorescence signal upon 
excitation with visible light, which makes it possible to have a real-time in situ 
monitoring of the localization and concentration of the drug (Bonnett, 2000b; Foley 
et al., 2006). It was observed that the short preincubation time (5-15 minutes) was 
adequate for the optimal effect, and the extension of the incubation period to 6 hours 
did not show further enhancement in the inactivation effect (data not shown). Hence, 
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it was surmised that the photosensitizer may have saturated the cellular 
compartments. When the uptake of BAM-SiPc as a function of time was analyzed, 
an initial rapid increase was observed for the first 30 minutes as expected. This 
suggested that the effective inactivation of photosensitizer could be achieved within 
30 minutes in the time-course study. However, the uptake continued with a slower 
rate afterwards up to 5 hours. The increase of intracellular BAM-SiPc without any 
improvement in cytotoxicity may be due to the metabolism of the photosensitizer 
inside the cells. Further studies are needed to confirm the current findings. 
Demidova and Hamblin (2005) suggested that there are three different modes 
of binding of photosensitizers, viz. those tightly bound and penetrate into the cell, 
those loosely bound, and those with no binding at all. Once photosensitizer is 
illuminated, it may exert its phototoxic effect inside or outside the cell. When it is 
outside the cell, ROS may first damage the cell wall, ultimately leading to cell death. 
Inside the cell, ROS may trigger apoptosis via damaging key players of metabolic 
pathways. In the present study, it was found that the photosensitizer BAM-SiPc 
retained considerable effect despite the washing step prior to illumination. Moreover, 
a strong fluorescence signal was observed throughout the cell under a fluorescence 
microscope. Both evidence tend to suggest that BAM-SiPc was tightly bound to the 
exterior of the cell wall and/or diffused into the Candida cells. 
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The localization of the photosensitizer is an important factor influencing the 
efficacy of the treatment as well as the cellular components to be attacked 
(Calzavara-Pinton et al., 2005). Therefore, in the next set of experiments, C L S M 
was used to track the BAM-SiPc inside the Candida cells. The confocal plane image 
can allow the differentiation of the interior and exterior localization of 
photosensitizers. Our results indicate that BAM-SiPc was distributed throughout the 
cell before illumination, similar to the case of Photofrin (Bliss et al., 2004). Thus, 
the mechanism of action of BAM-SiPc appears to differ from that of cationic 
porphyrin TriP[4] which is mainly located outside the cells initially with an influx 
only after illumination (Lambrechts et al., 2005). The early uptake associated with 
BAM-SiPc and its wide intracellular distribution imply that the chemical may target 
different intracellular components, including DNA, enzymes and other cellular 
structures. 
It is well established that gram negative bacteria are more resistant to some 
common photosensitizers than gram positive bacteria, and the use of cationic 
photosensitizers may improve the efficacy (Malik et al., 1992; Merchat et al., 1996). 
On the other hand, there is still no conclusion on whether the charge of the 
photosensitizer has any influence in the binding and uptake in C. albicans or other 
fungi. A comparative study of a cationic and an anionic phthalocyanine zine(II) 
complex for PDT on C. albicans was performed by Mantareva et al (2007). The 
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result indicated that there was no charge dependence for drug uptake in C. albicans, 
although a lower antifungal effect was observed with the anionic photosensitizer. 
This may imply that the use of cationic photosensitizers is preferable for C. albicans, 
yet further confirmation is needed. 
4.3.2 ROS as mediator of cell damage 
The basic mechanism of PDT to exert its photo-inactivation is via the 
generation of damaging ROS, which include singlet oxygen, hydrogen peroxide, 
radicals, etc. Of these, singlet oxygen is considered to be the most potent agent for 
PDT and primarily responsible for photodamage of cellular components (Wainwright, 
1998). In order to confirm whether ROS is generated during the treatment, D C F D A 
was used. D C F D A is a molecular probe that does not fluoresce by itself. Inside the 
cell, the acetate group of D C F D A can be hydrolyzed by intracellular esterase; the 
resultant species can then be oxidized by nearby ROS to produce a fluorescent 
product (Jakubowski and Bartosz, 2000; Bourre et al., 2002). Upon photodynamic 
treatment with 0.08 [iM of BAM-SiPc, there was a 3-4 fold increase in ROS 
generation. The dose-dependencies of ROS level and cell viability correlate well 
with each other, being consistent with the general belief that ROS is responsible for 
cell damage in PDT. Although D C F D A measures the amount of ROS other than 
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singlet oxygen, a previous study has shown that BAM-SiPc does generate singlet 
oxygen upon illumination (Lo et al., 2004). 
C L S M combined with D C F D A act as tools for investigation of the 
distribution of R O S generated after illumination. The resulting ROS was observed to 
be elevated throughout the entire cell, which agreed with the distribution of B A M -
SiPc. The cells in the dark control also showed some localized ROS signal, which 
appears to be the background level of ROS in the cells. The major sources of ROS in 
normal cells, such as mitochondria and peroxisomes (Schrader and Fahimi, 2006), 
are also present in the eukaryotic yeast cells and give the background ROS level. 
Early in the 1980s, scavengers of ROS have already been used for studying 
the role of R O S in PDT against yeast. For example, Stenstrom et al. (1980) used 
histidine and tryptophan while Ito (1981) used sodium azide as singlet oxygen 
scavengers for Hp mediated PDT on Saccharomyces cerevisiae. With the aim of 
elucidating the photochemical property of BAM-SiPc to see whether type I or type II 
mechanism is the predominant pathway for the cytotoxicity, a type I scavenger 
(histidine or sodium azide) and a type II scavenger (mannitol) were used. Hydroxyl 
radicals do not seem to be the critical damaging species as its scavenger, mannitol, 
did not show any protective effect for the cells. Meanwhile, histidine protected the 
cells from damage by the BAM-SiPc induced PDT. However, firm conclusions 
cannot be drawn at the present stage as sodium azide, also a singlet oxygen 
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scavenger, showed a contradictory effect as no protection was observed with this 
chemical. The different result may be due to the different quenching abilities and 
also the differences in uptake or localization of the two scavengers with respect to 
BAM-SiPc. 
4.3.3 Analysis of membrane integrity upon photodynamic treatment 
Different strategies have been used for the assessment of membrane integrity 
or membrane permeability of fungi treated with PDT. The first common strategy is 
by the penetration of a differentially permeable dye, e.g. SYTO-green (Giroldo et al., 
2007), acridine orange (Ito, 1977). The second is by monitoring the leakage of 
intracellular ions or protein (Paardekooper et al., 1995b). The third is by observing 
the morphology of the membrane with a freeze-fracture electron microscope 
(Lambrechts et al.’ 2005). 
In the late 1970s, Ito (1977) and Ito and Kobayashi (1977) proposed that 
membrane damage is the determining step in photodynamic inactivation of yeast 
with TBO. Since then, Hp (Stenstrom et al., 1980) and methylene blue (Giroldo et 
al., 2007) were also reported to have the cell membrane as the critical oxidative 
damage site. As a first attempt to study the target of ROS, the integrity of cell 
membrane after PDT was studied by using the high-affinity nucleic acid stain PI. 
Cells with an intact membrane should exclude PI from penetrating to interact with 
91 
Chapter 4 Discussion 
DNA. The flow cytometry results showed a significant increase in the cell 
population with high fluorescence intensity after photodynamic treatment with 
BAM-SiPc, indicating binding between PI and DNA. Such binding is possible only 
with the increase of cell membrane permeability. The dose-dependent results also 
correlated well with cell viability as well as ROS generation. In 1995, Paardekooper 
et al. (1995b) proposed that if photodynamic damage is causally related to the loss of 
clonogenicity, the dose-reponse curves for the two phenomena should be similar. In 
an investigation of utilizing a non-sulfonated chloroaluminium phthalocyanine to 
inactivate Kluyveromyes marxianus, K+ leakage only happens at much higher 
fluences than that required for cell killing. As a result, Paardekooper et al (1995b) 
came to the conclusion that the deterioration of cell membrane is not involved in the 
photo-inactivation. In the current study, the I C 5 0 value for BAM-SiPc mediated 
photo-inactivation was 0.011 |iM, while half of the C. albicans became permeable to 
PI at 0.014 \xM of BAM-SiPc. These findings suggest that membrane damage is 
critical for the cytotoxicity to occur. 
4.4 Establishment of the biofilm model of C. albicans 
Biofilm usually serves as a protective niche for microorganisms. It causes a 
greater resistance towards treatment with antibiotics or other antifungal agents. 
There is evidence that C. albicans biofilm grows rapidly in the modern society, 
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which is commonly associated with the use of indwelling medical devices, such as 
dentures, catheters and artificial joints (Ramage et al., 2006). Distinct from simply a 
fungal adhesion, biofilm formation in C. albicans is a much more complex 
phenomenon. There are three main developmental phases in the formation of C. 
albicans biofilm: early, intermediate and maturation phase. The formation of biofilm 
and the different stages are illustrated in Figure 4.1. The cells would proceed from 
attachment and micro-colony formation; filamentation and monolayer development; 
proliferation, production of extracellular matrix material and further maturation 
(Chandra et al., 2001; Ramage et al., 2001a; Nobile and Mitchell, 2006). There are a 
wide variety of parameters that influence the adhesion and formation of biofilm of C. 
albicans, including the strains, culture age and viability, culture medium and 
temperature of growth, germ-tube formation, culture concentration, cell surface 
hydrophobicity, surface chemistry of the material for attachment, and the flow 
condition of the environment (Gharmoum and Abu-Elteen, 1991; Li et al., 2003; 
Wesenberg-Ward et al” 2005; Al-Fattani and Douglas, 2006). 
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Figure 4.1 A schematic diagram for C. albicans biofilm formation, (a) and (b): 
Biofilm formation on polymethylmethacrylate (PMA) strips, (c) and (d): Biofilm 
formation on silicone elastomer (SE) disks. Panels (a) and (c) represent the substrate 
seen from the top, while panels (c) and (d) show the side-view images. Three 
developmental phases are indicated, namely early, intermediate and maturation phase. 
ECM, extracellular material. (Adopted from Chandra et al., 2001) 
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In the present study, biofilm of C. albicans was formed in order to mimic the 
in vivo situation, and the possibility of killing the cells in the tough biofilm with 
BAM-SiPc was evaluated. As there are numerous factors governing biofilm 
formation, the methodology of forming C. albicans biofilm was adopted from the 
Oral Biosciences Laboratory, Faculty of Dentistry, The University of Hong Kong 
(Thein et al., 2007). C. albicans isolate 192887g was used for the biofilm model 
because it has a high ability for forming a robust biofilm (Jin et al” 2003; 2005). 
The biofilm model was successfully established for the latter investigations. Among 
the growth conditions verified, the inoculation of 10^  cell/ml standardized cell 
suspension with the washing of unattached cells after the initial phase was most 
optimal for biofilm formation. 
4.5 In vitro effect of BAM-SiPc mediated PDT on C. albicans 
biofilm 
PACT is still in the early developing stage, and there are still very limited 
reports on its antifungal effect. Among the reports on antifungals and PDT, there is 
only a single case where the photo-inactivation of a fungal biofilm was attempted 
with the use of Photofrin (Chabrier-Rosello et al” 2005). In the latter study, different 
growth stages of C. albicans at 0 hour, 3 hours, 24 hours and 48 hours were tested. 
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All are significantly inactivated with the use of 10 )ig/ml Photofrin, an incubation 
time of 30 minutes and a total fluence of 18 Jcm'^. 
In the present study, the in vitro effect of BAM-SiPc was investigated with 
the established C. albicans biofilm model. X T T reduction assay was used for the 
determination of cell viability in biofilm. X T T is a tetrazolium salt that can be 
reduced by dehydrogenase to form a coloured formazan product. This assay has 
been used for antifungal susceptibility testing of various species of yeasts, including 
C. albicans (Meletiadis et a/., 2001; Knight et al” 2006). It has the advantages that 
the reduction assay has a good correlation with the viability of the biofilm cells and 
the water solubility of its formazan product simplifies complicated procedures 
involved in assays using other tetrazolium salts (e.g. MTT) (Tellier et al., 1992; 
Ramage et al., 2001b). The efficacy of the antifungal activity of BAM-SiPc was 
found to be not satisfactory under the conditions used in the present study. Only 10 
to 30 % reduction in the viability was observed with concentrations of BAM-SiPc up 
to 20 |iM. 
In respect of the low potency observed, another potent second generation 
photosensitizer, a novel glucoconjugated Pc 4, was employed to see whether there 
would be any improvement. This novel photosensitizer has two glucose groups 
conjugated to the phthalocyanine and shows high phototoxicity towards cancer cells 
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(Lo et al., 2007b). However, it did not show any significant improvement in the 
efficacy of antifungal effect against the C. albicans biofilm model (data not shown). 
Another viability assay, using the LIVE/DEAD BacLight Bacterial Viability 
kit, was employed to confirm the results of the photodynamic treatment. The kit is 
commonly used for the viability assay for bacteria. Recently, Jin et al (2005) 
proposed and confirmed that the probes, SYTO-9 and PI, are also reliable for the 
determination of viability of C. albicans biofilm, where the cells can be stained 
differentially and visualized under the microscope. This assay has the advantage 
over the X T T reduction assay that the actual morphology of the live and dead cells 
can be determined, while the XTT assay is quantitative in nature. The microscopic 
images also reflected that BAM-SiPc was not potent enough for the inactivation of C. 
albicans and that only a small portion of cells was stained by PI in the PDT 
experiment performed. 
When compared to the planktonic cells where >90% inactivation was 
achieved with 0.16 |iM BAM-SiPc, an increase in photosensitizer concentration by 
125-fold did not result in any satisfactory inactivation in the biofilm model. In fact, 
many studies have also reported that the biofilms of C. albicans are more resistant to 
the antibiotics than that in planktonic form. For example, Ramage et al. (2001a) 
demonstrated the increase resistance in C. albicans biofilm. The minimum inhibitory 
concentration for fluconazole against planktonic C. albicans was 4 |ig/ml，while the 
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sessile minimum inhibitory concentration at 50% inhibition was greater than 1024 
fig/ml for the biofilm. 
Different reasons have been proposed for the increased resistance in fungal 
biofilm. These factors include the physical barrier of the extracellular material; and 
the intrinsic resistance caused by genetic and biochemical alterations, such as 
decreased growth rate and nutrient limitation, expression of resistance genes (e.g. the 
genes encoding efflux pumps), and existence of persister cells (Chandra et al,, 2001; 
Nobile and Mitchell, 2006; Ramage et al., 2006). As a complex community, the 
resistance could be multifactorial and might not be explained with a single 
mechanism. 
The extracellular matrix is regarded as the physical barrier for the bacterial 
biofilms of some drugs (Hoyle and Costerton, 1991); however, its role in the fungal 
system is still unclear. The C L S M images in the present study indicate the intake of 
BAM-SiPc into the cells, and the 3D image of the biofilm shows that BAM-SiPc was 
able to penetrate into the cell population in both the top layer as well as the bottom 
layer, so it seems that the uptake of the photosensitizers should not be a major factor 
for the resistance. 
The production of ROS in the biofilm model (maximum of 2-fold increase at 
a high concentration of 20 |iM BAM-SiPc) was reduced with comparison to the 
planktonic one (3.5-fold increase with the use of 0.08 BAM-SiPc). The 
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reduction in the R O S production efficacy may be the determining factor as ROS is 
the critical damaging agent for the effect of PDT. However, the reason for the 
decrease in R O S production level remains to be determined. 
One possibility for the resistance may be due to the induction of enzymes in 
the cells in biofilm, which protect the cells from damage. To study such possibility, 
the biofilm was resuspended in order to see whether the resistance would persist or 
there would be a regain of sensitivity. If the resistance persists, it supports the idea 
of induction of cellular enzyme, while the regain of sensitivity may imply the linkage 
between the resistance and the matrix or structural integrity of the biofilm. 
The result showed that there was a regain of sensitivity of cells towards 
photodynamic treatment. The I C 5 0 value for the resuspended biofilm towards the 
BAM-SiPc mediated PDT was 0.03 |iM. This implies that the integrity of the 
biofilm structure was more important for the protection of cells from photo-
inactivation. The finding is totally different from the result of Ramage et al. (2002) 
in that the resuspended sessile C. albicans still show the resistance towards 
fluconazole. The different results may be due to the totally different killing 
mechanisms of the two treatments, in which the mechanisms of resistance may also 
not be the same. The genes for efflux pumps (e.g. CDR and MDR) are shown to be 
up-regulated and may cause the efflux of fluconazole, but that may not affect the 
killing by BAM-SiPc. As a result, the regain of sensitivity suggested that the factors 
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related to structural complexity, e.g. the establishment of microniches and ramifying 
water channels or the quorum sensing (Ramage et al., 2006), may play a role in the 
resistance of C. albicans biofilm towards BAM-SiPc mediated PDT. 
The sensitivity of the resuspended cells seems to be higher than that of the 
planktonic one ( I C 5 0 = 0.048 jiM). The reason for the enhanced potency on 
resuspended biofilm cells may be due to the scraping of the cells which causes some 
mechanical damage to the cells. Nevertheless, some investigations have indicated a 
greater sensitivity of hypae and psuedohyphae than that of yeast cells towards the 
biocide chlorhexidine- (Suci and Tyler, 2002) and also toluidine blue-mediated P D T 
(Jackson et al., 1999). 
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Conclusion and Future Perspectives 
5.1 Conclusion 
BAM-SiPc, a silicon(IV) derivative, was found to be effective in exerting 
high phototoxicity against the fungal pathogen C. albicans in the planktonic form, 
where the I C 5 0 was determined to be at sub-micro molar level. The cytotoxicity 
was dose-dependent and fluence-dependent and devoid of any dark toxicity. A 
higher cell density led to a lower inactivation efficacy. Optimal conditions of 
different parameters were determined. A short incubation time of 5 to 15 minutes 
was sufficient to allow the photosensitizer to exert its optimal antifungal activity. 
Washing away of unbound or PS in solution only slightly decreased the potency of 
BAM-SiPc, suggesting a tight interaction between BAM-SiPc and C. albicans. 
In the mechanistic study, a rapid uptake was observed in the first 30 minutes 
of the incubation. C L S M analysis of the fluorescence signal of BAM-SiPc 
indicates the uptake of BAM-SiPc into the intracellular part of C. albicans. ROS was 
confirmed to be elevated in a dose-dependent manner upon BAM-SiPc mediated 
PDT by the D C F D A assay, and it was distributed widely throughout the entire cell. 
The cell membrane was an obvious target for oxidative damage as reflected by the PI 
staining after PDT. The dose-dependent ROS production and membrane 
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permeability curves correlated well with each other, implying that the oxidative 
attack of the cell membrane might be one of the determining steps for the 
photoinactivation of C. albicans with BAM-SiPc. 
The biofilm model was successfully established with the C. albicans isolate 
192887g. However, subsequent investigation of the photodynamic inactivation by 
BAM-SiPc indicated biofilms are more resistant than planktonic counterparts. High 
resistance of the bioflm model was present under all the conditions examined. Both 
X T T reduction assay and molecular probe staining confirmed the low efficacy of 
BAM-SiPc against C. albicans biofilm. The uptake of BAM-SiPc was not the 
reason for the failure as the C L S M image showed an effective uptake of BAM-SiPc 
into different layers of the biofilm. The reduced ROS production might be one of the 
factors for the low efficacy, but the exact reason has yet to be determined. The 
regain of sensitivity of C. albicans in the resuspended biofilm indicates that the 
complexity and integrity of the biofilm structure were important for the protection 
against PACT. 
5.2 Future perspectives 
Analysis of intracellular damage 
Our result was in accordance with other investigations in that the 
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photodynamic inactivation is associated with membrane damage. However, further 
studies are needed to confirm the killing mechanism and the determining steps. 
Further investigations can be performed on the damage at a subcellular level, D N A 
damage (Catalfo et al., 2007) or inhibition of intracellular enzymes, e.g. alcohol 
dehydrogenase, cytochrome c oxidase (Paardekooper et al., 1995a), etc. 
Identifying the role of Type I and Type II mechanism 
The results of the effects of ROS scavengers, sodium azide, histidine and 
mannitol, were not conclusive in the present study. Superoxide assay with the use of 
nitroblue tetrazolium chloride (NBT) and singlet oxygen assay with the use of 
4-nitroso-N,N-dimethy 1 ani 1 ine (RNO) (Tegos et al., 2006) could be performed for 
further differentiation of type I and type II mechanism of BAM-SiPc mediated PDT 
on C. albicans. 
Mechanism of cell death -- Apoptosis and necrosis 
The mechanism of cell death is better resolved in cancer treatment. 
Intensive investigations have been done on the pathways of apoptosis and necrosis in 
cancer cells treated with PDT. Apoptosis or programmed cell death also exist in C. 
albicans (Madeo et al., 1997; Gourlay et al., 2006; Phillips et al., 2006). 
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Environmental stress or some well known antibiotics, such as amphotericin B, was 
found to induce apoptosis in C. albicans (Madeo et al., 1999; Phillips et al., 2003). 
However, there is no publication relating apoptosis in C. albicans with PDT. Most 
of the investigations are still in the preliminary stage of figuring out the possible 
antifungal photosensitizers. As a result, whether the killing of C. albicans with 
BAM-SiPc is related to apoptosis will be a new field of study. A different variety of 
parameters may be involved. Different death mechanisms may be induced by the 
same photosensitizer under different treatment conditions, for example incubation 
time, light dose, concentration of photosensitizer etc. 
Possibility of inactivating C. albicans biofilm 
PDT with BAM-SiPc in the biofilm model is not satisfactory under the 
conditions used in the present study. More detailed investigations of the 
mechanisms for the resistance towards BAM-SiPc treatment are needed to shed light 
on ways for improving the photosensitizers in PACT. 
In vivo model 
Up to now, only one in vivo study has been published for antifungal PDT, 
which is on the use of methylene blue in oral candidiasis in an immunodeficient 
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murine model (Teichert et al., 2002). This kind of in vivo study on the antifungal 
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